Creatd, Inc.
Consolidated Statements of Cash Flows
|
|
For the Year
Ended
|
|
|
For the Year
Ended
|
|
|
|
December 31,
2020
|
|
|
December 31,
2019
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
Net loss
|
|
$
|
(24,162,783
|
)
|
|
$
|
(8,035,372
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
157,760
|
|
|
|
57,492
|
|
Impairment of note receivable
|
|
|
11,450
|
|
|
|
-
|
|
Accretion of debt discount and issuance cost
|
|
|
4,303,072
|
|
|
|
348,665
|
|
Share-based compensation
|
|
|
6,861,163
|
|
|
|
437,106
|
|
Bad debt expense
|
|
|
53,692
|
|
|
|
33,503
|
|
Change in fair value of derivative liabilities
|
|
|
(3,019,457
|
)
|
|
|
-
|
|
Loss on settlement of vendor liabilities
|
|
|
126,087
|
|
|
|
(13,574
|
)
|
Loss on marketable securities
|
|
|
7,453
|
|
|
|
-
|
|
Loss on extinguishment of debt
|
|
|
5,586,012
|
|
|
|
162,860
|
|
Non-cash lease expense
|
|
|
72,553
|
|
|
|
60,764
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Prepaid expenses
|
|
|
(19,729
|
)
|
|
|
(3,458
|
)
|
Accounts receivable
|
|
|
(93,198
|
)
|
|
|
(54,174
|
)
|
Deposits and other assets
|
|
|
(4,829
|
)
|
|
|
-
|
|
Deferred revenue
|
|
|
37,946
|
|
|
|
41,686
|
|
Accounts payable and accrued expenses
|
|
|
2,880,392
|
|
|
|
985,715
|
|
Unrecognized tax benefit
|
|
|
(68,000
|
)
|
|
|
68,000
|
|
Warrant liability
|
|
|
-
|
|
|
|
10,000
|
|
Operating lease liability
|
|
|
(70,071
|
)
|
|
|
(56,240
|
)
|
Net Cash Used In Operating Activities
|
|
|
(7,340,487
|
)
|
|
|
(5,957,027
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Issuance of note receivable
|
|
|
-
|
|
|
|
(11,450
|
)
|
Cash paid for property and equipment
|
|
|
(44,988
|
)
|
|
|
(27,887
|
)
|
Cash paid for marketable securities
|
|
|
(248,272
|
)
|
|
|
-
|
|
Sale of marketable securities
|
|
|
36,048
|
|
|
|
-
|
|
Deposits
|
|
|
(175,000
|
)
|
|
|
-
|
|
Cash paid for equity investments in businesses
|
|
|
(115,000
|
)
|
|
|
-
|
|
Cash consideration for acquisition
|
|
|
-
|
|
|
|
(340,000
|
)
|
Net cash received in business combination
|
|
|
-
|
|
|
|
16,049
|
|
Net Cash Used In Investing Activities
|
|
|
(547,212
|
)
|
|
|
(363,288
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Cash overdraft
|
|
|
-
|
|
|
|
(33,573
|
)
|
Net proceeds from issuance of notes
|
|
|
1,501,661
|
|
|
|
-
|
|
Repayment of notes
|
|
|
(492,665
|
)
|
|
|
(50,000
|
)
|
Proceeds from issuance of demand loan
|
|
|
440,000
|
|
|
|
250,000
|
|
Repayment of demand Loan
|
|
|
(90,000
|
)
|
|
|
(25,000
|
)
|
Proceeds from issuance of convertible note
|
|
|
3,650,835
|
|
|
|
2,472,525
|
|
Repayment of convertible notes
|
|
|
(1,658,001
|
)
|
|
|
-
|
|
Proceeds from issuance of convertible notes - related party
|
|
|
50,000
|
|
|
|
-
|
|
Proceeds from issuance of note payable - related party
|
|
|
152,989
|
|
|
|
4,186,500
|
|
Repayment of note payable - related party
|
|
|
(983,752
|
)
|
|
|
(501,500
|
)
|
Proceeds from issuance of common stock and warrants
|
|
|
6,662,015
|
|
|
|
684,829
|
|
Net cash received for preferred series E and warrants
|
|
|
6,670,417
|
|
|
|
-
|
|
Cash paid for debt issuance costs
|
|
|
-
|
|
|
|
(35,000
|
)
|
Cash paid for stock issuance costs
|
|
|
-
|
|
|
|
(35,000
|
)
|
Purchase of treasury stock and warrants
|
|
|
(89,416
|
)
|
|
|
(575,834
|
)
|
Net Cash Provided By Financing Activities
|
|
|
15,814,083
|
|
|
|
6,337,947
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
(31,239
|
)
|
|
|
(5,995
|
)
|
|
|
|
|
|
|
|
|
|
Net Change in Cash
|
|
|
7,895,145
|
|
|
|
11,637
|
|
|
|
|
|
|
|
|
|
|
Cash - Beginning of Year
|
|
|
11,637
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Cash - End of period
|
|
$
|
7,906,782
|
|
|
$
|
11,637
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTARY CASH FLOW INFORMATION:
|
|
|
|
|
|
|
|
|
Cash Paid During the Year for:
|
|
|
|
|
|
|
|
|
Income taxes
|
|
$
|
-
|
|
|
$
|
-
|
|
Interest
|
|
$
|
178,461
|
|
|
$
|
55,987
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
Settlement of vendor liabilities
|
|
$
|
475,220
|
|
|
$
|
32,500
|
|
Conversion of marketable debt securities into equity securities
|
|
$
|
102,096
|
|
|
$
|
-
|
|
Deferred offering costs
|
|
$
|
-
|
|
|
$
|
143,146
|
|
Beneficial conversion feature on convertible notes
|
|
$
|
3,099,837
|
|
|
$
|
4,444
|
|
Warrants issued with debt
|
|
$
|
1,078,500
|
|
|
$
|
427,692
|
|
Shares issued with debt
|
|
$
|
243,741
|
|
|
$
|
-
|
|
Issuance of common stock for prepaid services
|
|
$
|
585,000
|
|
|
$
|
-
|
|
Cancellation of Treasury stock
|
|
$
|
374,184
|
|
|
$
|
-
|
|
Operating Lease liability
|
|
$
|
-
|
|
|
$
|
349,997
|
|
Conversion of note payable and interest into convertible notes
|
|
$
|
385,000
|
|
|
$
|
-
|
|
Conversion of Demand loan into notes payable
|
|
$
|
200,000
|
|
|
$
|
-
|
|
Common stock and warrants issued upon conversion of notes payable
|
|
$
|
11,217,362
|
|
|
$
|
-
|
|
Promissory Note issued for acquisition
|
|
$
|
-
|
|
|
$
|
660,000
|
|
Shares issued for acquisition
|
|
$
|
-
|
|
|
$
|
1,166,669
|
|
Conversion of note payable and interest into convertible notes
|
|
$
|
385,000
|
|
|
$
|
-
|
|
Conversion of note payable- related party and interest into convertible notes- related party
|
|
$
|
-
|
|
|
$
|
4,119
|
|
Conversion of accounts payable and interest into convertible notes
|
|
$
|
-
|
|
|
$
|
318,678
|
|
Conversion of interest into note payable - related party
|
|
$
|
-
|
|
|
$
|
128,992
|
|
Leasehold improvements reclassified to right-of-use asset
|
|
$
|
-
|
|
|
$
|
22,478
|
|
The accompanying notes are an integral
part of these consolidated financial statements.
Creatd, Inc.
December 31, 2020 and 2019
Notes to the Consolidated Financial
Statements
Note 1 – Organization and Operations
Creatd, Inc., formerly Jerrick Media Holdings,
Inc. (“we,” “us,” the “Company,” or “Creatd”), is a technology company focused
on the development of digital communities, marketing branded digital content, and e-commerce opportunities. Creatd’s content
distribution platform, Vocal, delivers a robust long-form, digital publishing platform organized into highly engaged niche-communities
capable of hosting all forms of rich media content. Through Creatd’s proprietary algorithm dynamics, Vocal enhances the visibility
of content and maximizes viewership, providing advertisers access to target markets that most closely match their interests.
The Company was originally incorporated
under the laws of the State of Nevada on December 30, 1999 under the name LILM, Inc. The Company changed its name on December 3,
2013 to Great Plains Holdings, Inc. as part of its plan to diversify its business.
On February 5, 2016 (the “Closing
Date”), GTPH, GPH Merger Sub, Inc., a Nevada corporation and wholly-owned subsidiary of GTPH (“Merger Sub”),
and Jerrick Ventures, Inc., a privately-held Nevada corporation headquartered in New Jersey (“Jerrick”), entered into
an Agreement and Plan of Merger (the “Merger”) pursuant to which the Merger Sub was merged with and into Jerrick, with
Jerrick surviving as a wholly-owned subsidiary of GTPH (the “Merger”). GTPH acquired, pursuant to the Merger, all of
the outstanding capital stock of Jerrick in exchange for issuing Jerrick’s shareholders (the “Jerrick Shareholders”),
pro-rata, a total of 475,000 shares of GTPH’s common stock. In connection therewith, GTPH acquired 33,415 shares of Jerrick’s
Series A Convertible Preferred Stock (the “Jerrick Series A Preferred”) and 8,064 shares of Series B Convertible Preferred
Stock (the “Jerrick Series B Preferred”).
In connection with the Merger, on the Closing
Date, GTPH and Kent Campbell entered into a Spin-Off Agreement (the “Spin-Off Agreement”), pursuant to which Mr. Campbell
purchased from GTPH (i) all of GTPH’s interest in Ashland Holdings, LLC, a Florida limited liability company, and (ii) all
of GTPH’s interest in Lil Marc, Inc., a Utah corporation, in exchange for the cancellation of 39,091 shares of GTPH’s
Common Stock held by Mr. Campbell. In addition, Mr. Campbell assumed all debts, obligations and liabilities of GTPH, including
any existing prior to the Merger, pursuant to the terms and conditions of the Spin-Off Agreement.
Upon closing of the Merger on February
5, 2016, the Company changed its business plan to that of Jerrick.
Effective February 28, 2016, GTPH entered
into an Agreement and Plan of Merger (the “Statutory Merger Agreement”) with Jerrick, pursuant to which GTPH became
the parent company of Jerrick Ventures, LLC, a wholly-owned operating subsidiary of Jerrick (the “Statutory Merger”)
and GTPH changed its name to Jerrick Media Holdings, Inc. to better reflect its new business strategy.
On September 11, 2019, the Company acquired
100% of the membership interests of Seller’s Choice, LLC, a New Jersey limited liability company (“Seller’s Choice”).
Seller’s Choice is digital e-commerce agency based in New Jersey (see Note 4).
On September 9, 2020, the Company filed
a certificate of amendment with the Secretary of State of the State of Nevada to change our name to “Creatd, Inc.”,
which became effective on September 10, 2020.
Note 2 – Significant and Critical
Accounting Policies and Practices
Management of the Company is responsible
for the selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application.
Critical accounting policies and practices are those that are both most important to the portrayal of the Company’s financial
condition and results and require management’s most difficult, subjective, or complex judgments, often as a result of the
need to make estimates about the effects of matters that are inherently uncertain. The Company’s significant and critical
accounting policies and practices are disclosed below as required by the accounting principles generally accepted in the United
States of America.
Use of Estimates and Critical Accounting Estimates and Assumptions
The preparation of financial statements
in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts
of revenues and expenses during the reporting periods.
These significant accounting estimates
or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions,
and certain estimates or assumptions are difficult to measure or value.
Management bases its estimates on historical
experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole
under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources.
Management regularly evaluates the key
factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances,
historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.
Actual results could differ from those
estimates.
Principles of consolidation
The Company consolidates all majority-owned
subsidiaries, if any, in which the parent’s power to control exists.
As of December 31, 2020, the Company’s
consolidated subsidiaries and/or entities are as follows:
Name of combined affiliate
|
|
State or other jurisdiction of
incorporation or organization
|
|
|
Company
Ownership Interest
|
|
|
|
|
|
|
|
|
Jerrick Ventures LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
Abacus Tech Pty Ltd
|
|
|
Australia
|
|
|
|
100
|
%
|
Seller’s Choice, LLC
|
|
|
New Jersey
|
|
|
|
100
|
%
|
Jerrick Global, LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
Jerrick Investment Advisors LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
Jerrick Partners LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
Maven Tech LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
OG Collection LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
VMENA LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
Vocal For Brands, LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
Vocal Ventures LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
What to Buy, LLC
|
|
|
Delaware
|
|
|
|
100
|
%
|
All inter-company balances and transactions
have been eliminated.
Fair Value of Financial Instruments
The
fair value measurement disclosures are grouped into three levels based on valuation factors:
|
●
|
Level 1 – quoted prices in active markets for identical investments
|
|
●
|
Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)
|
|
●
|
Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)
|
The Company’s Level 1 assets/liabilities
include cash, accounts receivable, marketable trading securities, accounts payable, prepaid and other current assets, line of credit and due to related parties.
Management believes the estimated fair value of these accounts at December 31, 2020 approximate their carrying value as reflected
in the balance sheets due to the short-term nature of these instruments or the use of market interest rates for debt instruments.
The Company’s Level 2 assets/liabilities
include certain of the Company’s notes payable and capital lease obligations. Their carrying value approximates their fair
values based upon a comparison of the interest rate and terms of such debt given the level of risk to the rates and terms of similar
debt currently available to the Company in the marketplace.
The Company’s Level 3 assets/liabilities include goodwill,
intangible assets, marketable debt securities, equity investments at cost,
and derivative liabilities, when they are recorded at fair value due to an impairment charge. Inputs to determine fair value are generally
unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset
or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash
flow models. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities.
The following table provides a summary of the
relevant assets and liabilities that are measured at fair value on recurring basis:
Fair Value Measurements as of
December 31, 2020
|
|
Total
|
|
|
Quoted
Prices
in Active
Markets for
Identical
Assets or
Liabilities
(Level 1)
|
|
|
Quoted
Prices
for Similar
Assets or
Liabilities in
Active
Markets
(Level 2)
|
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable securities - debt securities
|
|
$
|
62,733
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
62,733
|
|
Marketable securities - equity securities
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Goodwill
|
|
|
1,035,795
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,035,795
|
|
Total assets
|
|
$
|
1,098,528
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,098,528
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
42,231
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
42,231
|
|
Total Liabilities
|
|
|
42,231
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
42,231
|
|
The following table shows the valuation methodology
and unobservable inputs for Level 3 assets and liabilities measured at fair value on recurring basis as of December 31, 2020:
|
|
Fair Value
|
|
|
Valuation Methodology
|
|
Unobservable Inputs
|
|
|
|
|
|
|
|
|
Marketable securities - debt securities
|
|
$
|
62,733
|
|
|
Discounted cash flow analysis
|
|
Expected cash flows from the investment
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
$
|
1,035,795
|
|
|
Qualitative assessment per ASC 350-20-35
|
|
Discounted cash flow models
|
|
|
|
|
|
|
|
|
Qualitative
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
42,231
|
|
|
Monte Carlo simulations
|
|
Risk free rate
|
|
|
|
|
|
|
|
|
Expected volatility
|
|
|
|
|
|
|
|
|
Drift rate
|
The following table provides a summary of the
relevant assets that are measured at fair value on non-recurring basis:
Fair Value Measurements as of
December 31, 2020
|
|
Total
|
|
|
Quoted
Prices
in Active
Markets for
Identical
Assets or
Liabilities
(Level 1)
|
|
|
Quoted
Prices
for Similar
Assets or
Liabilities in
Active
Markets
(Level 2)
|
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity investments, at cost
|
|
$
|
217,096
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
217,096
|
|
Intangible assets
|
|
|
960,611
|
|
|
|
-
|
|
|
|
-
|
|
|
|
960,611
|
|
Total assets
|
|
$
|
1,177,707
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,177,707
|
|
The following table shows the valuation methodology
and unobservable inputs for Level 3 assets measured at fair value on non-recurring basis as of December 31, 2020:
|
|
Fair Value
|
|
|
Valuation Methodology
|
|
Unobservable Inputs
|
|
|
|
|
|
|
|
|
Equity investments, at cost
|
|
$
|
217,096
|
|
|
Qualitative assessment per ASC 321-10-35
|
|
Qualitative factors
|
|
|
|
|
|
|
|
|
|
Intangible assets
|
|
$
|
960,611
|
|
|
Lesser of cost or fair value
|
|
Discounted cash flow models
Qualitative factors such as the value of customer attrition
estimates, trade names and trademarks
|
The Company valued the initial value of
debt securities, which are investments in convertible notes receivable, by assessing the separate values of the debt and equity
components for similar instruments convertible into private company equity (Level 3). The investment was initially measured at
cost, which was determined to approximate fair value due to the lack of marketability of the conversion shares underlying these
convertible instruments and the expected recoverability of the note principal. The key assumption affecting the level 3 fair values
would be collectability of the notes. The Company monitors for impairment indicators at each balance sheet date.
Marketable debt securities as of December
31, 2020 are as follows:
|
|
Fair
Value
Hierarchy
|
|
|
Cost
|
|
|
Unrealized
Gains
(Loss)
|
|
|
Fair
Value
|
|
Marketable securities - debt securities
|
|
3
|
|
|
$
|
62,733
|
|
|
$
|
-
|
|
|
$
|
62,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The change in net unrealized holding gain
(loss) on debt securities available for sale that has been included in Accumulated Other Comprehensive Income as a separate component
of Stockholder’s Equity for the year ended December 31, 2020 and 2019 was $0 and $0, respectively.
The Company recognizes impairment on loans
or notes receivable (that do not meet the definition of a debt security) when it is probable that it will be unable to collect
all amounts due according to the contractual terms, and the amount of loss can be estimated. The loss is estimated based on the
present value of expected cash flows. The Company recognized a $50,000 credit loss on debt marketable securities.
Our marketable equity securities are publicly
traded stocks measured at fair value using quoted prices for identical assets in active markets and classified as Level 1 within
the fair value hierarchy. Marketable equity securities as of December 31, 2020 are $0.
The change in net realized depreciation on equity trading securities
that has been included in other expenses for the year ended December 31, 2020 and 2019 was $(7,453) and $0, respectively.
Cash Equivalents
The Company considers all highly liquid
investments with a maturity of three months or less when purchased to be cash equivalents.
At times, cash balances may exceed the Federal Deposit Insurance Corporation
(“FDIC”) insurable limits. The Company has never experienced any losses related to these balances. As of December 31, 2020,
and 2019, cash amounts in excess of $250,000 were not fully insured. The uninsured cash balance as of December 31, 2020 was approximately
$7.7 million. The Company does not believe it is exposed to significant credit risk on cash and cash equivalents.
Property and Equipment
Property and equipment are recorded at
cost. Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred.
Depreciation is computed by the straight-line method (after taking into account their respective estimated residual values) over
the estimated useful lives of the respective assets as follows:
|
|
Estimated
Useful Life
(Years)
|
|
|
|
Computer equipment and software
|
|
3
|
Furniture and fixtures
|
|
5
|
Upon sale or retirement of property and
equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the
consolidated statements of operations.
Long-lived Assets Including Goodwill
and Other Acquired Intangibles Assets
We evaluate the recoverability of property
and equipment and acquired finite-lived intangible assets for possible impairment whenever events or circumstances indicate that
the carrying amount of such assets may not be recoverable. The evaluation is performed at the lowest level for which identifiable
cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured
by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate from the use
and eventual disposition. If such review indicates that the carrying amount of property and equipment and intangible assets is
not recoverable, the carrying amount of such assets is reduced to fair value. We have not recorded any significant impairment charges
during the year ended December 31, 2020.
Acquired finite-lived intangible assets
are amortized on a straight-line basis over the estimated useful lives of the assets. We routinely review the remaining estimated
useful lives of property and equipment and finite-lived intangible assets. If we change the estimated useful life assumption for
any asset, the remaining unamortized balance is amortized or depreciated over the revised estimated useful life.
During the year ended December 31, 2020
the Company completed its annual impairment test of goodwill. The Company performed the qualitative assessment as permitted by
ASC 350-20 and determined that the fair value of the reporting unit was more likely than not equal or greater than the carrying
value, including Goodwill. Based on completion of this annual impairment test, no impairment was indicated.
Investments
Marketable securities that are bought and held
principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with
unrealized gains and losses recognized in earnings. Debt securities not classified as held-to-maturity or as trading are classified as
available-for-sale, and are carried at fair market value, with the unrealized gains and losses, net of tax, included in the determination
of comprehensive income and reported in stockholders’ equity.
The Company accounts for its investments in available-for-sale
debt securities, in accordance with sub-topic 320-10 of the FASB ASC (“Sub-Topic 320-10”). Accrued interest on these securities
is included in fair value and amortized cost.
Pursuant to Paragraph 320-10-35, investments in
debt securities that are classified as available for sale shall be measured subsequently at fair value in the statement of financial position.
Unrealized holding gains and losses for available-for-sale securities (including those classified as current assets) shall be excluded
from earnings and reported in other comprehensive income until realized.
The Company follows FASB ASC 320-10-35 to assess
whether an investment in debt securities is impaired in each reporting period. An investment in debt securities is impaired if the fair
value of the investment is less than its amortized cost. If the Company intends to sell the debt security (that is, it has decided to
sell the security), an other-than-temporary impairment shall be considered to have occurred. If the Company more likely than not will
be required to sell the security before recovery of its amortized cost basis or it otherwise does not expect to recover the entire amortized
cost basis of the security, an other-than-temporary impairment shall be considered to have occurred. The Company considers the expected
cash flows from the investment based on reasonable and supportable forecasts as well as several other factors to estimate whether a credit
loss exists. If the Company intends to sell the security or more likely than not will be required to sell the security before recovery
of its amortized cost basis less any current-period credit loss, the other-than-temporary impairment shall be recognized in earnings equal
to the entire difference between the investment’s amortized cost basis and its fair value at the balance sheet date.
The following table sets forth a summary of the changes in marketable
securities - available-for-sale debt securities that are measured at fair value on a recurring basis:
|
|
For the year
ended
December 31,
2020
|
|
|
|
Total
|
|
Beginning of period
|
|
$
|
-
|
|
Purchase of marketable securities
|
|
|
210,000
|
|
Interest due at maturity
|
|
|
4,829
|
|
Other than temporary impairment
|
|
|
(50,000
|
)
|
Conversion of marketable securities
|
|
|
(102,096
|
)
|
December 31, 2020
|
|
$
|
62,733
|
|
The following table sets forth a summary of the changes in marketable
securities – trading equity securities that are measured at fair value on a recurring basis:
|
|
For the year
ended
December 31,
2020
|
|
|
|
Total
|
|
Beginning of period
|
|
$
|
-
|
|
Purchase of marketable securities
|
|
|
38,272
|
|
Loss on trading securities
|
|
|
(7,453
|
)
|
Sale of marketable securities
|
|
|
(30,819
|
)
|
December 31, 2020
|
|
$
|
-
|
|
We invest in debt and equity securities. Our investments in debt securities
are subject to interest rate risk. To minimize the exposure due to an adverse shift in interest rates, we invest in securities with maturities
of two years or less and maintain a weighted average maturity of one year or less. As of December 31, 2020, all
of our investments had maturities between one and three years. The marketable security investments are evaluated for impairment
if events or circumstances arise that indicate that the carrying amount of such assets may not be recoverable. On October 2, 2020, the
Company converted $102,096 of a marketable debt security into 1.3% equity investment. The Company recognized an allowance for a credit
loss on debt marketable securities.
The following table sets forth a summary of the changes in equity investments,
at cost that are measured at fair value on a non-recurring basis:
|
|
For the year
ended
December 31,
2020
|
|
|
|
Total
|
|
Beginning of period
|
|
$
|
-
|
|
Purchase of equity investments
|
|
|
115,000
|
|
Conversion of marketable securities
|
|
|
102,096
|
|
December 31, 2020
|
|
$
|
217,096
|
|
The Company has elected
to measure its equity securities without a readily determinable fair value at cost minus impairment, if any, plus or minus changes resulting
from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. An election to measure
an equity security in accordance with this paragraph shall be made for each investment separately.
The Company performed a qualitative assessment
considering impairment indicators to evaluate whether these investments were impaired. Impairment indicators that the Company considered
included the following: a) a significant deterioration in the earnings performance, credit rating, asset quality or business prospects
of the investee; b) a significant adverse change in the regulatory, economic or technology environment of the investee; c) a significant
adverse change in the general market condition of either the geographical area or the industry in which the investee operates; d) a bona
fide offer to purchase or an offer by the investee to sell the investment; e) factors that raise significant concerns about the investee’s
ability to continue as a going concern.
Commitments and Contingencies
The Company follows subtopic 450-20 of the FASB ASC to report
accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which
may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The
Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss
contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings,
the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the
amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates that it is probable
that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be
accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency
is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability,
and an estimate of the range of possible losses, if determinable and material, would be disclosed.
Loss contingencies considered remote are
generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.
Foreign Currency
Foreign currency denominated assets and
liabilities are translated into U.S. dollars using the exchange rates in effect at our Consolidated Balance Sheet dates. Results
of operations and cash flows are translated using the average exchange rates throughout the periods. The effect of exchange rate
fluctuations on the translation of assets and liabilities is included as a component of stockholders’ equity in accumulated
other comprehensive income. Gains and losses from foreign currency transactions, which are included in SG&A, have not been
significant in any period presented.
Derivative Liability
The Company evaluates its debt and equity
issuances to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted
for in accordance with paragraph 815-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of
this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded
as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded
in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative
instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair
value is reclassified to equity.
In circumstances where the embedded conversion
option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the
convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single,
compound derivative instrument.
The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting
period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to
liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified
in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected
within 12 months of the balance sheet date.
The Company adopted Section 815-40-15 of
the FASB Accounting Standards Codification (“Section 815-40-15”) to determine whether an instrument (or an embedded
feature) is indexed to the Company’s own stock. Section 815-40-15 provides that an entity should use a two-step approach
to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating
the instrument’s contingent exercise and settlement provisions. The Company changed its method of accounting for
the debt and warrants through the early adoption of ASU 2017-11 during the three months ended December 31, 2017 on a retrospective
basis.
The Company utilizes an Geometric Brownian Motion (“GBM”)
model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet
date. The inputs utilized in the application of the GBM model included a starting stock price, an expected term of each debenture
remaining from the valuation date to maturity, an estimated volatility, and a risk-free rate. The Company records the change in
the fair value of the derivative as other income or expense in the consolidated statements of operations.
Revenue Recognition
Under Topic 606, revenue is recognized
when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we
expect to be entitled to in exchange for those goods or services.
We determine revenue recognition through
the following steps:
|
●
|
identification of the contract, or contracts, with a customer;
|
|
|
|
|
●
|
identification of the performance obligations in the contract;
|
|
●
|
determination of the transaction price. The transaction price for any given subscriber could decrease based on any payments made to that subscriber. A subscriber may be eligible for payment through one or more of the monetization features offered to Vocal creators, including earnings through reads (on a cost per mille basis) and cash prizes offered to Challenge winners;
|
|
●
|
allocation of the transaction price to the performance obligations in the contract; and
|
|
|
|
|
●
|
recognition of revenue when, or as, we satisfy a performance obligation.
|
Revenue disaggregated by revenue source
for the year ended December 31, 2020 and 2019 consists of the following:
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2020
|
|
|
2019
|
|
Managed Services
|
|
$
|
747,174
|
|
|
$
|
283,332
|
|
Branded content
|
|
|
353,025
|
|
|
|
107,335
|
|
Creator Subscriptions
|
|
|
70,623
|
|
|
|
31,997
|
|
Affiliate sales
|
|
|
33,748
|
|
|
|
15,300
|
|
Other revenue
|
|
|
8,300
|
|
|
|
15,042
|
|
|
|
$
|
1,212,870
|
|
|
$
|
453,0066
|
|
Managed Services
The Company provides Studio/Agency Service offerings to business-to-business
(B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions.
The Company’s services include the setup and ongoing management of clients’ websites, Amazon and Shopify storefronts and
listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for
sales and growth optimization. Contracts are broken into three categories Partners, Monthly Services, and Projects. Contract amounts
for Partner and Monthly Services clients range from approximately $500-$7,500 per month while Project amounts vary depending on the scope
of work. Partner and Monthly clients are billed monthly for the work completed within that month. Partner Clients may or may not have
an additional billing component referred to as Sales Performance Fee, which is a fee based upon a previously agreed upon percentage point
of the client’s total sales for the month. Some Partners may also have projects within their contracts that get billed and recognized
as agreed upon project milestones are achieved. Revenue is recognized over time as service obligations and milestones in the contract
are met.
Branded Content
Branded content represents the revenue
recognized from the Company’s obligation to create and publish branded articles for clients on the Vocal platform and promote
said stories, tracking engagement for the client. The performance obligation is satisfied when the Company successfully publishes
the articles on its platform and meets any required promotional milestones as per the contract. The revenue is recognized over
time as the services are performed and any required milestones are met.
Below are the significant components of
a typical agreement pertaining to branded content revenue:
|
●
|
The Company collects fixed fees ranging from $10,000 to $110,000.
|
|
|
|
|
●
|
The articles are created and published within three months of the signed agreement, or as previously negotiated with the client.
|
|
|
|
|
●
|
The articles are promoted per the contract and engagement reports are provided to the client.
|
|
|
|
|
●
|
Most billing
for contracts occurs 50% at signing and 50% upon completion of the services, with net payment terms varying per client.
|
|
|
|
|
●
|
Most contracts include provisions for clients to acquire content rights at the end of the campaign for a flat fee.
|
Creator Subscriptions
Vocal+ is a premium subscription offering
for Vocal creators. In addition to joining for free, Vocal creators now have the option to sign up for a Vocal+ membership
for either $9.99 monthly or $99 annually, though these amounts are occasionally subject to promotional discounts. Vocal+ subscribers
receive access to value-added features such as increased rate of cost per mille (thousand) (“CPM”) monetization, a
decreased minimum withdrawal threshold, a discount on platform processing fees, member badges for their profiles, access to exclusive
Vocal+ Challenges, and early access to new Vocal features. Subscription revenues stem from both monthly and annual subscriptions,
the latter of which is amortized over a twelve-month period. Any customer payments received are recognized over the subscription
period, with any payments received in advance being deferred until they are earned.
The transaction price for any given subscriber could decrease based on any payments made to that subscriber.
A subscriber may be eligible for payment through one or more of the monetization features offered to Vocal creators, including
earnings through reads (on a cost per mille basis) and cash prizes offered to Challenge winners. Estimates are utilized for payments
made for earnings through reads, by establishing the lifetime a subscriber has had a Vocal account, determining the percentage
of that lifetime that the subscriber has been a paying customer, and applying that percentage to payments for earnings through
reads in the relevant reporting period.
Affiliate Sales
Affiliate sales represents the commission the Company receives
when a purchase is made through affiliate links placed within content hosted on the Vocal platform. Affiliate revenue is earned
on a “click through” basis, upon referring visitors, via said links, to an affiliate’s site and having them complete
a specific outcome, most commonly a product purchase. The Company uses multiple affiliate platforms, such as Skimlinks, Amazon,
and Tune, to form and maintain thousands of vendor relationships. Each vendor establishes their own commission percentage, which
typically range from 2-20%. The revenue is recognized upon receipt as reliable estimates could not be made.
Deferred Revenue
Deferred revenue consists of billings and
payments from clients in advance of revenue recognition. As of December 31, 2020 and 2019, the Company had deferred revenue
of $88,637 and $50,691, respectively.
Accounts Receivable and Allowances
Accounts receivable are recorded and carried when the Company
has performed the work in accordance with managed services, project, partner, consulting and branded content agreements. For example,
we bill a managed service client monthly when we have updated their Amazon store, modified SEO or completed the other services
listed in the agreement. For projects and branded content, we will bill the client and record the receivable once milestones are
reached that are set in the agreement. We make estimates for the allowance for doubtful accounts and allowance for unbilled receivables
based upon our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit
quality of our customers, current economic conditions, and other factors that may affect our ability to collect from customers.
During the year ended December 31, 2020 the Company recorded $53,692 as a bad debt expense. As of December 31, 2020 and 2019, the
Company has an allowance for doubtful accounts of $80,509 and $33,503, respectively.
Stock-Based Compensation
The Company recognizes compensation expense
for all equity–based payments granted in accordance with Accounting Standards Codification (“ASC”) 718 “Compensation
– Stock Compensation”. Under fair value recognition provisions, the Company recognizes equity–based
compensation net of an estimated forfeiture rate and recognizes compensation cost only for those shares expected to vest over the
requisite service period of the award.
Restricted stock awards are granted at
the discretion of the Company. These awards are restricted as to the transfer of ownership and generally vest over the requisite
service periods, typically over a five-year period (vesting on a straight–line basis). The fair value of a stock award is
equal to the fair market value of a share of Company stock on the grant date.
The fair value of an option award is estimated
on the date of grant using the Black–Scholes option valuation model. The Black–Scholes option valuation model requires
the development of assumptions that are inputs into the model. These assumptions are the value of the underlying share, the expected
stock volatility, the risk–free interest rate, the expected life of the option, the dividend yield on the underlying stock
and the expected forfeiture rate. Expected volatility is benchmarked against similar companies in a similar industry over the expected
option life and other appropriate factors. Risk–free interest rates are calculated based on continuously compounded risk–free
rates for the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends
on its Common stock and does not intend to pay dividends on its Common stock in the foreseeable future. The expected forfeiture
rate is estimated based on management’s best estimate.
Determining the appropriate fair value
model and calculating the fair value of equity–based payment awards requires the input of the subjective assumptions described
above. The assumptions used in calculating the fair value of equity–based payment awards represent management’s best
estimates, which involve inherent uncertainties and the application of management’s judgment. As a result, if factors change
and the Company uses different assumptions, our equity–based compensation could be materially different in the future. The
Company issues awards of equity instruments, such as stock options and restricted stock units, to employees and certain non-employee
directors. Compensation expense related to these awards is based on the fair value of the underlying stock on the award date and
is amortized over the service period, defined as the vesting period, using the straight-line method. The vesting period is generally
five years. A Black-Scholes model is utilized to estimate the fair value of stock options, while the market price of the Company’s
common stock at the date of grant is used for restricted stock units. Compensation expense is reduced for actual forfeitures as
they occur.
Income Taxes
Income taxes are provided in accordance
with ASC No. 740, “Accounting for Income Taxes”. A deferred tax asset or liability is recorded for all temporary
differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from
the net change during the period of deferred tax assets and liabilities.
Deferred tax assets are reduced by a valuation
allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will
not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date
of enactment.
Management makes judgments as to the interpretation
of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the
Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion,
adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates,
additional allowances or reversals of reserves may be necessary.
During the year
ended December 31, 2020 and 2019, we recognized a $507,242 and $292,383 respectively, benefit for research and development tax
credits in other income on the Statements of Comprehensive Income (Loss). The tax credits were claimed on our previous Australian
tax returns and were based upon a research and development costs paid to an Australian company.
Loss Per Share
Basic net loss per common share is computed by dividing net
loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted
net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted
for the dilutive effect of common stock equivalents. In periods when losses are reported, which is the case for the year ended
December 31, 2020 and 2019 presented in these consolidated financial statements, the weighted-average number of common shares outstanding
excludes common stock equivalents because their inclusion would be anti-dilutive.
The Company had the following common stock
equivalents at December 31, 2020 and 2019:
|
|
December 31,
|
|
|
|
2020
|
|
|
2019
|
|
Options
|
|
|
541,021
|
|
|
|
911,500
|
|
Warrants
|
|
|
3,228,235
|
|
|
|
742,221
|
|
Convertible notes - related party
|
|
|
-
|
|
|
|
5,438
|
|
Convertible notes
|
|
|
-
|
|
|
|
724,751
|
|
Totals
|
|
|
3,769,256
|
|
|
|
2,383,910
|
|
Recently Adopted Accounting Guidance
The Company invests in equity and debt
securities. The Company’s investments in debt securities are classified at the date of purchase as available-for-sale securities.
Debt securities are reported at fair value with unrealized gains and losses, net of the related tax effect, reflected as an accumulated
other comprehensive income component of stockholder’s equity until such gains or losses are realized. In accordance with
Accounting Standards Update (“ASU”) 2016-01, Equity securities are now reported at fair value with unrealized gains
and losses, net of the related tax effect, reflected as a gain or loss on the statement of operations.
In November 2019, the FASB issued ASU No. 2019-10,
“Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): The mandatory
effective dates for Credit Losses in this Update (ASU 2019-10) are as follows: 1. Public business entities that meet the definition of
an SEC filer, excluding entities eligible to be SRCs as defined by the SEC, for fiscal years beginning after December 15, 2019, including
interim periods within those 2. All other entities for fiscal years beginning after December 15, 2022, including interim periods within
those fiscal years. The adoption of ASU 2019-10 had a material impact on the Company’s Consolidated Financial Statements because
it deferred the adoption of ASU 2016-13.
In October 2016, the FASB issued ASU 2016-16,
“Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory”, which eliminates the exception that prohibits
the recognition of current and deferred income tax effects for intra-entity transfers of assets other than inventory until the asset
has been sold to an outside party. The updated guidance is effective for annual periods beginning after December 15, 2019, including
interim periods within those fiscal years. Early adoption of the update is permitted. The adoption of ASU 2016-16 did not have a material
impact on the Company’s consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill
and Other (Topic 350): Simplifying the Test for Goodwill Impairment, which eliminates the requirement to calculate the implied
fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead,
entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (i.e.,
measure the charge based on the current Step 1). The updated guidance, which became effective for fiscal years beginning after
December 15, 2019, did not have a material impact on the Company’s consolidated financial statements.
In August 2018,
the FASB issued ASU 2018-13, Fair Value Measurement - Disclosure Framework (Topic 820). The updated guidance improves
the disclosure requirements for fair value measurements. The adoption of ASU 2018-13 did not have a material impact on the
Company’s consolidated financial statements.
In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill
and Other - Internal Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing
Arrangement That is a Service Contract. This guidance requires companies to apply the internal-use software guidance in ASC
350-40 to implementation costs incurred in a hosting arrangement that is a service contract to determine whether to capitalize
certain implementation costs or expense them as incurred. The adoption of ASU 2018-15 did not have a material impact on the Company’s
consolidated financial statements.
Recent Accounting
Guidance Not Yet Adopted
In December 2019, the FASB issued authoritative
guidance intended to simplify the accounting for income taxes (ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting
for Income Taxes”). This guidance eliminates certain exceptions to the general approach to the income tax accounting model
and adds new guidance to reduce the complexity in accounting for income taxes. This guidance is effective for annual periods after
December 15, 2020, including interim periods within those annual periods. The Company is currently evaluating the potential impact
of this guidance on its consolidated financial statements.
In August 2020, the FASB issued ASU 2020-06,
Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s
Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU amends
the guidance on convertible instruments and the derivatives scope exception for contracts in an entity’s own equity, and
also improves and amends the related EPS guidance for both Subtopics. The ASU will be effective for annual reporting periods after
December 15, 2021 and interim periods within those annual periods and early adoption is permitted. The Company is currently evaluating
the impact of the new guidance on its consolidated financial statements.
Management does not believe that any recently issued, but not
yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements.
Note 3 – Going Concern
The Company’s consolidated financial statements have been
prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets,
and liquidation of liabilities in the normal course of business.
As reflected in the consolidated financial statements, as of
December 31, 2020, the Company had an accumulated deficit of $71.8 million, a net loss of $24.2 million and net cash used in operating
activities of $7.3 million for the reporting period then ended. The Company is in default on debentures as of the date of this
filing. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period
of one year from the issuance of these financial statements.
On January 30, 2020, the World Health Organization
declared the COVID-19 novel coronavirus outbreak a “Public Health Emergency of International Concern” and on March
10, 2020, declared it to be a pandemic. Actions taken around the world to help mitigate the spread of the coronavirus include restrictions
on travel, and quarantines in certain areas, and forced closures for certain types of public places and businesses. The COVID-19
coronavirus and actions taken to mitigate it have had and are expected to continue to have an adverse impact on the economies and
financial markets of many countries, including the geographical area in which the Company operates. While it is unknown how long
these conditions will last and what the complete financial impact will be to the Company, capital raising efforts and our operations
may be negatively affected.
The Company is attempting to further implement
its business plan and generate sufficient revenues; however, its cash position may not be sufficient to support its daily operations.
While the Company believes in the viability of its strategy to further implement its business plan and generate sufficient revenues
and in its ability to raise additional funds by way of a public or private offering of its debt or equity securities, there can
be no assurance that it will be able to do so on reasonable terms, or at all. The ability of the Company to continue as a going
concern is dependent upon its ability to further implement its business plan and generate sufficient revenues and its ability to
raise additional funds by way of a public or private offering.
The consolidated financial statements do
not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification
of liabilities that might be necessary should the Company be unable to continue as a going concern.
Note 4 – Acquisition of Seller’s
Choice
On September 11, 2019, the Company entered
into a Membership Interest Purchase Agreement (the “Seller’s Choice Purchase Agreement”) by and between the Company
and Home Revolution, LLC, a Delaware limited liability company (the “Seller”). Pursuant to the Seller’s Choice
Purchase Agreement, subject to the terms and conditions set forth therein, at the closing of the transactions contemplated by the
Seller’s Choice Purchase Agreement (the “Seller’s Choice Closing”), the Company acquired 100% of the membership
interests of Seller’s Choice. As a result of the transactions contemplated by the Seller’s Choice Purchase Agreement,
Seller’s Choice became a wholly owned subsidiary of the Company (collectively, the “Seller’s Choice Acquisition”).
At the Seller’s Choice Closing, the
aggregate consideration (the “Consideration”) paid to the Seller was as follows: (i) $340,000, in cash; (ii) 111,111
shares of the Company’s common stock; and (iii) a secured promissory note in the principal amount of $660,000 (the “Seller’s
Choice Note”). In connection with the Seller’s Choice Note, the Company, Seller, and Seller’s Choice entered
into a Security Agreement whereby the Seller’s Choice Note is secured by the assets of Seller’s Choice.
Following the closing of the transaction, Seller’s Choice’s
financial statements as of the Closing were consolidated with the consolidated financial statements of the Company. These amounts
are provisional and may be adjusted during the measurement period.
Following the closing of the merger transaction
the Company’s investment in Seller’s Choice consisted of the following:
|
|
Shares
|
|
|
Amount
|
|
Consideration paid:
|
|
|
|
|
|
|
|
|
Cash paid
|
|
|
|
|
|
$
|
340,000
|
|
Common stock issued at closing (1)
|
|
|
111,111
|
|
|
|
1,166,669
|
|
Note payable
|
|
|
|
|
|
|
660,000
|
|
Total consideration paid
|
|
|
|
|
|
$
|
2,166,669
|
|
|
|
|
|
|
|
|
|
|
Total consideration
|
|
|
|
|
|
$
|
2,166,669
|
|
(1)
|
The common stock issued at the closing of the Seller’s Choice Acquisition had a closing price of $10.50 per share on the date of the transaction.
|
The following presents the unaudited pro-forma
combined results of operations of the Company with Seller’s Choice as if the entities were combined on January 1, 2019.
|
|
Year Ended
|
|
|
|
December 31,
2019
|
|
Revenues, net
|
|
$
|
1,121,521
|
|
Net loss attributable to common shareholders
|
|
$
|
(8,176,763
|
)
|
Net loss per share
|
|
$
|
(2.90
|
)
|
Weighted average number of shares outstanding
|
|
|
2,818,365
|
|
The unaudited pro-forma results of operations
are presented for information purposes only. The unaudited pro-forma results of operations are not intended to present actual results
that would have been attained had the acquisition been completed as of January 1, 2019 or to project potential operating results
as of any future date or for any future periods.
The Company consolidated Seller’s
Choice as of the closing date of the Seller’s Choice Acquisition, and the results of operations of the Company since that
date include that of Seller’s Choice.
Note 5 – Property and Equipment
Property and equipment stated at cost,
less accumulated depreciation and amortization, consisted of the following:
|
|
December 31,
2020
|
|
|
December 31,
2019
|
|
Computer Equipment
|
|
$
|
284,928
|
|
|
$
|
239,940
|
|
Furniture and Fixtures
|
|
|
86,888
|
|
|
|
86,888
|
|
Leasehold Improvements
|
|
|
-
|
|
|
|
-
|
|
|
|
|
371,816
|
|
|
|
326,828
|
|
Less: Accumulated Depreciation
|
|
|
(315,558
|
)
|
|
|
(284,465
|
)
|
|
|
$
|
56,258
|
|
|
$
|
42,363
|
|
During the year ended December 31,
2019 the Company reclassified leasehold improvements to right of use asset in accordance with the adoption of ASU 2016-02. See
Note 10.
Depreciation expense
was $31,094 and $19,053 for the year ended December 31, 2020 and 2019, respectively.
Note 6 - Equity investments, at cost
The
Company has elected to measure its equity securities without a readily determinable fair value at cost minus impairment, if any,
plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment
of the same issuer. An election to measure an equity security in accordance with this paragraph shall be made for each investment
separately.
The Company
performed a qualitative assessment considering impairment indicators to evaluate whether these investments were impaired. Impairment
indicators that the Company considered included the following: a) a significant deterioration in the earnings performance, credit
rating, asset quality or business prospects of the investee; b) a significant adverse change in the regulatory, economic or technology
environment of the investee; c) a significant adverse change in the general market condition of either the geographical area or
the industry in which the investee operates; d) a bona fide offer to purchase or an offer by the investee to sell the investment;
e) factors that raise significant concerns about the investee’s ability to continue as a going concern.
On October 2, 2020, the
Company converted $102,096 of its marketable debt security into 119,355 shares of preferred stock or a 1.3% equity investment in a private
company.
On October 23, 2020,
the Company entered into a membership interest purchase agreement whereas the Company purchased 3.8% ownership of a private company for
$115,000.
Note 7 – Notes Payable
Notes payable as of December 31, 2020 and
2019 is as follows:
|
|
Outstanding Principal as of
|
|
|
|
|
|
|
|
|
December 31,
2020
|
|
|
December 31,
2019
|
|
|
Interest
Rate
|
|
|
Maturity Date
|
Seller’s Choice Note
|
|
$
|
660,000
|
|
|
$
|
660,000
|
|
|
|
30
|
%
|
|
September 2020
|
The First March 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
25
|
%
|
|
September 2020
|
The Second March 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
19
|
%
|
|
September 2021
|
The May 2020 PPP Loan Agreement
|
|
|
412,500
|
|
|
|
-
|
|
|
|
1
|
%
|
|
April 2022
|
The April 2020 PPP Loan Agreement
|
|
|
282,432
|
|
|
|
-
|
|
|
|
1
|
%
|
|
May 2022
|
The June 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
15
|
%
|
|
July 2020
|
The September 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
12.5
|
%
|
|
March 2021
|
The November 2020 Loan Agreement
|
|
|
23,716
|
|
|
|
-
|
|
|
|
14
|
%
|
|
May 2021
|
|
|
|
1,378,648
|
|
|
|
660,000
|
|
|
|
|
|
|
|
Less: Debt Discount
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
Less: Debt Issuance Costs
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
1,378,648
|
|
|
|
660,000
|
|
|
|
|
|
|
|
Less: Current Debt
|
|
|
(1,185,611
|
)
|
|
|
-
|
|
|
|
|
|
|
|
Total Long-Term Debt
|
|
$
|
193,037
|
|
|
$
|
-
|
|
|
|
|
|
|
|
As of December 31, 2020, if PPP loans payable are not forgiven, remaining
scheduled principal payments due on notes payable are as follows:
Twelve months ended December 31,
|
|
|
|
2021
|
|
$
|
1,185,611
|
|
2022
|
|
|
193,037
|
|
|
|
$
|
1,378,648
|
|
Seller’s Choice Note
On September 11, 2019, the Company entered into Seller’s
Choice Purchase Agreement with Home Revolution LLC (see Note 4). As a part of the consideration provided pursuant to the Seller’s
Choice Acquisition, the Company issued the Seller’s Choice Note to the Seller in the principal amount of $660,000. The Seller’s
Choice Note bears interest at a rate of 9.5% per annum and is payable on March 11, 2020 (the “Seller’s Choice Maturity
Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts become due. Upon maturity the
Company utilized an automatic extension up to 6 months. This resulted in a 5% increase in the interest rate every month the Seller’s
Choice Note is outstanding. As of December 31, 2020 the Company is in default on the Seller’s Choice note.
During the year ended December 31, 2019
the Company repaid $0 in principal and $16,198 in interest on the Seller’s Choice Note.
During the year ended December 31, 2020
the Company accrued interest of $154,485 and paid $68,970 of interest.
The First March 2020 Loan Agreement
On March 23, 2020, the Company entered
into a loan agreement (the “First March 2020 Loan Agreement”) with an individual (the “First March 2020 Lender”)
whereby the First March 2020 Lender issued the Company a promissory note of $11,000 (the “First March 2020 Note”).
Pursuant to the First March 2020 Loan Agreement, the First March 2020 Note has an effective interest rate of 25%. The maturity
date of the First March 2020 Note was September 23, 2020 (the “First March 2020 Maturity Date”), at which time all
outstanding principal, accrued and unpaid interest and other amounts due under the First March 2020 Note were due.
During the year ended December 31, 2020,
the Company repaid $11,000 in principal and $2,695 in interest.
The Second March 2020 Loan Agreement
On March 26, 2020, the Company entered
into a loan agreement (the “Second March 2020 Loan Agreement”) with an individual (the “Second March 2020 Lender”),
whereby the Second March 2020 Lender issued the Company a promissory note of $17,000 (the “Second March 2020 Note”).
Pursuant to the Second March 2020 Loan Agreement, the Second March 2020 Note has an effective interest rate of 19%. The maturity
date of the Second March 2020 Note was September 17, 2020 (the “Second March 2020 Maturity Date”), at which time all
outstanding principal, accrued and unpaid interest and other amounts due under the Second March 2020 Note were due.
During the year ended December 31, 2020,
the Company repaid $17,000 in principal and $1,398 in interest.
The April 2020 PPP Loan Agreement
On April 30, 2020, the Company was granted a loan with a principal
amount of $282,432 (the “Loan”), pursuant to the Paycheck Protection Program (the “PPP”) under Division
A, Title I of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), which was enacted on March
27, 2020. The Loan, which was in the form of a Note dated April 30, 2020 matures on April 30, 2022 and bears interest at a fixed
rate of 1.00% per annum, payable monthly commencing on October 30, 2020. The Note may be prepaid by the Company at any time prior
to maturity without payment of any premium. Funds from the Loan may only be used to retain workers and maintain payroll or make
mortgage payments, lease payments and utility payments.
During the year ended December 31, 2020,
the Company accrued interest of $1,896.
The Company is in the process of returning
the funds received from the Loan.
When the applications for PPP first opened
up, there was limited available funding and much confusion surrounding the application process. The Company initially submitted
its application for the May 2020 PPP Loan in early April but received no response in the aftermath of submitting the application.
After consulting multiple advisors, the Company made the decision to apply elsewhere, due to the rampant media coverage of institutions
running out of funding and the Company’s need for the capital and belief that if 2 separate loans were approved, the remaining
application could simply be withdrawn.
Therefore, in late April, the company proceeded
with applying for the April 2020 PPP Loan. After some conflicting communications regarding acceptance, the Company attempted to
contact the lender to clarify but got no response. After continued attempts to follow up with both lenders, the Company received
approval for the May 2020 PPP Loan and funding for the April 2020 PPP Loan on the same day, followed the next day by the funding
of the May 2020 PPP Loan. The Company immediately separated the funds for the April 2020 PPP Loan into a separate reserved bank
account with the intention of returning the funds. However, after several attempts to contact the lender with no response, the
Company was faced with difficulty raising funds in the early-Covid economy and made the decision to utilize the funds for operations
and pursue an installment repayment plan when they were able to reach the lender. As of the date of this filing, the Company has
begun making repayments on the loan, absent a formal installment agreement due to difficulties reaching the lender. The Company
intends to complete repayment before the end of 2021.
As each
company is only permitted one loan under the CARES Act, there is a possibility the loan bay be called by the SBA and the Company
would have to repay the loan in full at such time.
The May 2020 PPP Loan Agreement
On May 4, 2020, Jerrick Ventures, LLC (“Jerrick
Ventures”), the Company’s wholly-owned subsidiary, was granted a loan from PNC Bank, N.A. with a principal amount of
$412,500, pursuant to the Paycheck Protection Program (the “PPP”). The Loan, which was in the form of a Note dated
May 4, 2020 matures on May 4, 2022 and bears interest at a fixed rate of 1.00% per annum, payable monthly commencing on November
4, 2020. The Note may be prepaid by Jerrick Ventures at any time prior to maturity without payment of any premium. Funds from the
Loan may only be used to retain workers and maintain payroll or make mortgage payments, lease payments and utility payments. Jerrick
Ventures intends to use the entire Loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the Loan
may be forgiven if they are used for qualifying expenses as described in the CARES Act.
During the year ended December 31, 2020,
the Company accrued interest of $2,724.
The Company plans to apply for forgiveness of this loan and has begun discussions with the lender regarding
that process.
The June 2020 Loan Agreement
On June 30, 2020, the Company entered into
a loan agreement (the “June 2020 Loan Agreement”) with a banking institution (the “June 2020 Lender”),
whereby the June 2020 Lender issued the Company a promissory note of A$510,649 Australian dollar (“AUD”) or $351,692
United States Dollar (the “June 2020 Note”). Pursuant to the June 2020 Loan Agreement, the June 2020 Note has an effective
interest rate of 15%. The maturity date of the June 2020 Note was July 31, 2020 (the “June 2020 Maturity Date”) at
which time all outstanding principal, accrued and unpaid interest and other amounts due under the June 2020 Note were due in AUD
currency. This loan was secured by the Australian research & development credit.
During the year ended December
31, 2020 the Company repaid A$510,649 in principal and A$14,814 in interest.
The September 2020 Loan Agreement
On September 1, 2020, the Company entered
into a loan agreement (the “September 2020 Loan Agreement”) with a lender (the “September 2020 Lender”)
whereby the September 2020 Lender issued the Company a promissory note of $25,000 (the “September 2020 Note”). Pursuant
to the September 2020 Loan Agreement, the September 2020 Note has an effective interest rate of 12.5%. The maturity date of the
September 2020 Note is March 1, 2021 (the “September 2020 Maturity Date”), at which time all outstanding principal,
accrued and unpaid interest and other amounts due under the September 2020 Note are due.
During the year ended December 31, 2020,
the Company repaid $25,000 in principal and $2,834 in interest.
The October 2020 Loan Agreement
On October 6, 2020, the Company entered
into a secured loan agreement (the “October 2020 Loan Agreement”) with a lender (the “October 2020 Lender”),
whereby the October 2020 Lender issued the Company a secured promissory note of A$74,300 AUD or $53,128 United States Dollars (the
“October 2020 Note”). Pursuant to the October 2020 Loan Agreement, the October 2020 Note has an effective interest
rate of 14%. The maturity date of the October 2020 Note is September 30, 2021 (the “October 2020 Maturity Date”) at
which time all outstanding principal, accrued and unpaid interest and other amounts due under the October 2020 Loan Agreement are
due. The loan is secured by the Australian research & development credit.
During the year ended December
31, 2020 the Company accrued A$2,451 in interest.
The November 2020 Loan Agreement
On November
24, 2020, the Company entered into a loan agreement (the “November 2020 Loan Agreement”) with a lender (the
“November 2020 Lender”) whereby the November 2020 Lender issued the Company a promissory note of $34,000 (the “November
2020 Note”). Pursuant to the November 2020 Loan Agreement, the November 2020 Note has an effective interest rate of 14%.
The maturity date of the November 2020 Note is May 25, 2021 (the “November 2020 Maturity Date”), at which time all
outstanding principal, accrued and unpaid interest and other amounts due under the November 2020 Note are due.
During the year ended December 31, 2020,
the Company repaid $10,284 in principal.
Note 8 – Convertible Note Payable
Convertible notes payable as of December
31, 2020 and 2019 is as follows:
|
|
Outstanding
Principal
as of
|
|
|
|
|
|
|
|
|
|
|
Warrants
granted
|
|
|
|
December
31,
2020
|
|
|
December 31,
2019
|
|
|
Interest
Rate
|
|
|
Conversion
Price
|
|
|
Maturity
Date
|
|
Quantity
|
|
|
Exercise
Price
|
|
The February 2018 Convertible Note Offering
|
|
$
|
-
|
|
|
$
|
75,000
|
|
|
|
15
|
%
|
|
$
|
12.00
|
(*)
|
|
January – February 2020
|
|
|
84,639
|
|
|
|
12.00
|
|
The March 2018 Convertible Note Offering
|
|
|
-
|
|
|
|
75,000
|
|
|
|
14
|
%
|
|
|
12.00
|
(*)
|
|
March – April 2020
|
|
|
80,114
|
|
|
|
12.00
|
|
The February 2019 Convertible Note Offering
|
|
|
-
|
|
|
|
2,311,703
|
|
|
|
10
|
%
|
|
|
15.00
|
(*)
|
|
February – March 2020
|
|
|
44,396
|
|
|
|
18.00
|
|
The November 2019 Convertible Note Offering
|
|
|
-
|
|
|
|
559,433
|
|
|
|
12
|
%
|
|
|
13.50
|
(*)
|
|
May – June 2020
|
|
|
-
|
|
|
|
-
|
|
The First January 2020 convertible Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
12
|
%
|
|
$
|
13.50
|
(*)
|
|
July – August 2020
|
|
|
-
|
|
|
|
-
|
|
The First February 2020 convertible Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
10
|
%
|
|
$
|
12.00
|
(*)
|
|
August 2020
|
|
|
-
|
|
|
|
-
|
|
The Second February 2020 convertible Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
12
|
%
|
|
$
|
13.50
|
(*)
|
|
February 2021
|
|
|
6,666
|
|
|
|
15.00
|
|
The Third February 2020 convertible Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
12
|
%
|
|
$
|
13.50
|
(*)
|
|
February 2021
|
|
|
41,665
|
|
|
|
15.00
|
|
The April 2020 Convertible Note Offering
|
|
|
-
|
|
|
|
-
|
|
|
|
12
|
%
|
|
$
|
13.50
|
(*)
|
|
October 2020
|
|
|
-
|
|
|
|
-
|
|
The June 2020 Convertible Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
12
|
%
|
|
$
|
-
|
(*)
|
|
June 2021
|
|
|
49,603
|
|
|
|
11.55
|
|
The First July 2020 convertible Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
10
|
%
|
|
$
|
-
|
(*)
|
|
June 2021
|
|
|
-
|
|
|
|
-
|
|
The Second July 2020 convertible Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
12
|
%
|
|
$
|
-
|
(*)
|
|
July 2021
|
|
|
6,667
|
|
|
|
12
|
|
The July 2020 Convertible Note Offering
|
|
|
-
|
|
|
|
-
|
|
|
|
10
|
%
|
|
$
|
12.75
|
(*)
|
|
January – March 2021
|
|
|
30,589
|
|
|
|
12.75
|
|
The August 2020 convertible Loan Agreement
|
|
|
|
|
|
|
|
|
|
|
10
|
%
|
|
$
|
-
|
(*)
|
|
August 2021
|
|
|
-
|
|
|
|
-
|
|
The September 2020 convertible
Loan Agreement
|
|
|
341,880
|
|
|
|
-
|
|
|
|
12
|
%
|
|
$
|
-
|
(*)
|
|
September 2021
|
|
|
85,555
|
|
|
|
5
|
|
The October 2020 convertible
Loan Agreement
|
|
|
169,400
|
|
|
|
-
|
|
|
|
6
|
%
|
|
$
|
-
|
(*)
|
|
October 2021
|
|
|
-
|
|
|
|
-
|
|
The First December 2020 convertible
Loan Agreement
|
|
|
600,000
|
|
|
|
-
|
|
|
|
12
|
%
|
|
$
|
-
|
(*)
|
|
December 2021
|
|
|
-
|
|
|
|
-
|
|
The Second December 2020
convertible Loan Agreement
|
|
|
169,400
|
|
|
|
-
|
|
|
|
6
|
%
|
|
$
|
-
|
(*)
|
|
December 2021
|
|
|
-
|
|
|
|
-
|
|
|
|
|
1,280,680
|
|
|
|
3,021,136
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Debt Discount
|
|
|
(309,637
|
)
|
|
|
(124,096
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Debt Issuance Costs
|
|
|
(73,527
|
)
|
|
|
(614
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
897,516
|
|
|
|
2,896,425
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Current Debt
|
|
|
(897,516
|
)
|
|
|
(2,896,425
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Long-Term Debt
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(*)
|
As subject to adjustment as further outlined in the notes
|
The February 2018 Convertible Note
Offering
During the three months ended March 31,
2018, the Company conducted multiple closings of a private placement offering to accredited investors (the “February 2018
Convertible Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited
investors” (the “February 2018 Investors”) for aggregate gross proceeds of $725,000. In addition, $250,000 of
the Company’s short-term debt along with accrued but unpaid interest of $40,675 was exchanged for convertible debt in the
February 2018 Offering. These conversions resulted in the issuance of 24,223 warrants with a fair value of $181,139. These were
recorded as a loss on extinguishment of debt.
The February 2018 Convertible Note Offering
consisted of a maximum of $750,000 of units of the Company’s securities (each, a “February 2018 Unit” and collectively,
the “February 2018 Units”), with each February 2018 Unit consisting of (a) a 15% Convertible Secured Promissory Note
(each a “February 2018 Convertible Note” and together the “February 2018 Convertible Notes”), convertible
into shares of the Company’s common stock, par value $.001 per share (“February 2018 Conversion Shares”) at a
conversion price of $12.00 per share (the “February 2018 Note Conversion Price”), and (b) a five-year warrant (each
a “February 2018 Offering Warrant and together the “February 2018 Offering Warrants”) to purchase common stock
equal to one hundred percent (100%) of the shares into which the February 2018 Convertible Notes can be converted into (“February
2018 Warrant Shares”) at an exercise price of $12.00 per share (“February 2018 Warrant Exercise Price”). The
February 2018 Offering Notes mature on the second (2nd) anniversary of their issuance dates. The February 2018 Offering Notes are
secured by a second priority security interest in the Company’s assets up to $1,000,000.
The February 2018 Note Conversion Price
and the February 2018 Offering Warrant Exercise Price are subject to adjustment for issuances of the Company’s common stock
or any equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than
the prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being
reduced to such lower purchase price, subject to carve-outs as described therein.
The conversion feature of the February
2018 Convertible Note Offering provides for an effective conversion price that is below market value on the date of issuance. Such
feature is normally characterized as a beneficial conversion feature (“BCF”). When the Company records a BCF the relative
fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The Company recorded
a BCF and related debt discount of $37,350, the discount is being accreted over the life of the first Debenture to accretion of
debt discount and issuance cost.
The Company recorded a $316,875 debt discount
relating to 60,416 February 2018 Offering Warrants issued to investors based on the relative fair value of each equity instrument
on the dates of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance
cost.
In connection with the February 2018 Convertible
Note Offering, the Company retained a placement agent (the “Placement Agent”), to carry out the Offering on a “best-efforts”
basis. For services in its capacity as Placement Agent, the Company has paid the Placement Agent a cash fee of $94,250 and issued
to the Placement Agent shares of the Company’s common stock equal to ten percent (10%) of the Conversion Shares underlying
the February 2018 Convertible Notes or 6,041 shares that had a fair value of $74,881, which was recorded as issuance cost and is
being accreted over the life of these notes to accretion of debt discount and issuance cost.
During the year ended December 31, 2018,
the Company converted $940,675 of principal and $86,544 of unpaid interest into the August 2018 Equity Raise.
During the year ended December 31, 2019
the Company repaid $19,758 in interest.
During the year ended December 31, 2020
the Company repaid $75,000 in principal and $781 in interest, and the February 2018 Convertible Notes are no longer outstanding.
The March 2018 Convertible Note Offering
During the three months ended March 31,
2018, the Company conducted multiple closings of a private placement offering to accredited investors (the “March 2018 Convertible
Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited
investors” (the “March 2018 Investors”) for aggregate gross proceeds of $770,000. In addition, $50,000 of the
Company’s short-term debt, $767 accrued but unpaid interest and $140,600 of the Company’s vendor liabilities was exchanged
for convertible debt within the March 2018 Convertible Note Offering. These conversions resulted in the issuance of 15,947 warrants
with a fair value of $84,087. These were recorded as a loss on extinguishment of debt.
The March 2018 Convertible Note Offering
consisted of a maximum of $900,000, with an over-allotment option of an additional $300,000 of units of the Company’s securities
(each, a “March 2018 Unit” and collectively, the “March 2018 Units”), with each March 2018 Unit consisting
of (a) a 14% Convertible Secured Promissory Note (each a “March 2018 Note” and together the “March 2018 Notes”),
convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at a conversion
price of $12.00 per share (the “Conversion Price”), and (b) a four-year warrant (each a “Warrant and together
the “Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the Notes can
be converted into (“Warrant Shares”) at an exercise price of $12.00 per share (“Exercise Price”). The March
2018 Notes mature on the second (2nd) anniversary of their issuance dates.
The Conversion Price of the March 2018
Note and the Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any
equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the
prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced
to such lower purchase price, subject to carve-outs as described therein.
The Company recorded a $254,788 debt discount
relating to 80,114 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance.
The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2018,
the Company converted $886,367 of principal and $51,293 of unpaid interest pursuant to the August 2018 Equity Raise.
During the year ended December 31, 2020, the Company converted $50,000 of principal and $17,949 of unpaid interest into the September 2020 Equity Raise.
During the year ended December 31, 2020,
the Company repaid $25,000 in principal and $9,364 in interest.
The February 2019 Convertible Note
Offering
During the year ended December 31, 2019,
the Company conducted an offering to accredited investors (the “February 2019 Convertible Note Offering”) of units
of the Company’s securities by entering into subscription agreements with “accredited investors” (the “February
2019 Investors”) for aggregate gross proceeds of $1,993,025.
The February 2019 Convertible Note Offering
consisted of (a) a 10% Convertible Promissory Note (each a “February 2019 Note” and together, the “February 2019
Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”)
at the lesser of (i) a fixed conversion price equal to $15.00 per share or (ii) the price provided to investors in connection with
(a) any private placement offerings or one or more registered public offerings by the Company under the Securities Act, pursuant
to which the Company receives monies in the amount greater than $1,500,000 in exchange for securities of the Company between February
21, 2019 and the date on which the Company’s consummates a listing onto a national securities exchange, or (b) any private
placement offerings or one or more registered public offerings by the Company under the Securities Act in connection with its listing
onto a national securities exchange (a “Qualified Offering”), and (b) a four-year stock purchase warrant (each a “Warrant
and together the “Warrants”) to purchase a quantity of shares of the Company’s common stock up to thirty-three
percent (33%) of the number of shares of common stock into which the underlying Notes may be converted, at an exercise price of
$18.00 per share (“Exercise Price”). During the year ended December 31, 2019 a total of 44,396 Warrants were issued
in conjunction with The February 2019 Convertible Note Offering.
The February 2019 Notes mature on the first
(1st) anniversary of their issuance dates. In the event that the Offering’s Purchasers do not choose to convert
the Notes into the Common Stock on or prior to the Maturity Dates, the principal and interest evidenced by the Note shall be mandatorily
converted upon the earlier of (i) the listing of the Common Stock onto a national securities exchange, or (ii) upon a Qualified
Offering.
The Conversion Price of the February 2019
Note and the Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any
equity linked instruments or securities convertible into the Company’s common stock at a purchase price of less than the
prevailing Conversion Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced
to such lower purchase price, subject to carve-outs as described therein.
The Company recorded a $222,632 debt discount
relating to 44,396 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance.
The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2020,
the Company converted $1,963,567 of principal and $416,786 of unpaid interest into the September 2020 Equity Raise.
During the year ended December 31, 2020,
the Company repaid $348,136 in principal and $0 in interest.
The November 2019 Convertible Note
Offering
During the year ended December 31, 2019,
the Company conducted an offering to accredited investors (the “November 2019 Convertible Note Offering”) of units
of the Company’s securities by entering into subscription agreements with “accredited investors” (the “November
2019 Investors”) for aggregate gross proceeds of $479,500. In addition, the Company converted $318,678 in Accounts Payable
into this offering.
The November 2019 Convertible Note Offering
consisted of (a) a 10% Convertible Promissory Note (each a “November 2019 Note” and together, the “November 2019
Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”)
at a fixed conversion price equal to $13.50 per share.
The November 2019 Notes mature six months
after the anniversary of their issuance dates. At any time on or after the maturity date, at the election of the Offering’s
Purchaser, this Note may convert into Common Stock equal to the quotient obtained by dividing the outstanding principal and unpaid
accrued interest of this Note on the date of such conversion by $13.50.
The Company recorded a $84,377 debt discount
relating to an original issue discount equal to $79,933 and a beneficial conversion feature of $4,444. The debt discount is being
accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2020,
the Company converted $559,433 of principal and $77,785 of unpaid interest into the September 2020 Equity Raise.
The January 2020 Convertible Note
Offering
During the three months ended March 31,
2020, the Company conducted an offering to accredited investors (the “January 2020 Convertible Note Offering”) of units
of the Company’s securities by entering into subscription agreements with “accredited investors” (the “January
2020 Investors”) for aggregate gross proceeds of $87,473.
The January 2020 Convertible Note Offering
consisted of (a) a 12% Convertible Promissory Note (each a “January 2020 Note” and together, the “January 2020
Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”)
at the lesser of (i) a fixed conversion price equal to $13.50 per share or (ii) the price provided to investors in connection with
(a) any private placement offerings or one or more registered public offerings by the Company under the Securities Act, pursuant
to which the Company receives monies in the amount greater than $1,500,000 in exchange for securities of the Company, or (b) any
private placement offerings or one or more registered public offerings by the Company under the Securities Act in connection with
its listing onto a national securities exchange (a “Qualified Offering”).
The January 2020 Notes mature on the first
(6th) month anniversary of their issuance dates. If an event of default occurs and is not cured within 30 days
of the Company receiving notice, the notes will be convertible at 80% multiplied by the lowest VWAP of the common stock during
the five (5) consecutive trading day period immediately preceding the date of the respective conversion, and a default interest
rate of 24% will become effective.
The Conversion Price of the January 2020
Note are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities
convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise
Price. Such adjustment shall result in the Conversion Price being reduced to such lower purchase price, subject to carve-outs as
described therein.
The Company recorded a $12,473 debt discount
relating to original issue discount associated with these notes. The debt discount is being accreted over the life of the note
to accretion of debt discount and issuance cost.
During the year ended December 31, 2020,
the Company converted $87,473 of principal and $8,275 of unpaid interest into the September 2020 Equity Raise.
The First February 2020 Convertible
Loan Agreement
On February 4, 2020, the Company entered
into a loan agreement (the “First February 2020 Loan Agreement”) with an individual (the “First February 2020
Lender”), whereby the First February 2020 Lender issued the Company a promissory note of $85,000 (the “First February
2020 Note”). Pursuant to the First February 2020 Loan Agreement, the First February 2020 Note has interest of ten percent
(10%).
The First February 2020 Note are convertible
into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at the lesser of (i)
a fixed conversion price equal to $12.00 per share or (ii) the price provided to investors in connection with (a) any private placement
offerings or one or more registered public offerings by the Company under the Securities Act, pursuant to which the Company receives
monies in the amount greater than $1,500,000 in exchange for securities of the Company, or (b) any private placement offerings
or one or more registered public offerings by the Company under the Securities Act in connection with its listing onto a national
securities exchange (a “Qualified Offering”).
The First February 2020 Notes mature on
the first (6th) month anniversary of their issuance dates. In the event that the Offering’s Purchasers do
not choose to convert the Notes into the Common Stock on or prior to the Maturity Dates and the Notes have not been repaid or an
event of default occurs as defined in the Notes, the notes will be convertible at the lesser of the fixed conversion price or 65%
multiplied by the lowest trade of the common stock during the twenty (20) consecutive trading day period immediately preceding
the date of the respective conversion and a default interest rate of 15% will be applied.
The Conversion Price of the First February
2020 Note are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities
convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise
Price. Such adjustment shall result in the Conversion Price being reduced to such lower purchase price, subject to carve-outs as
described therein.
The Company recorded a $8,000 debt discount
relating to original issue discount associated with these notes. The debt discount is being accreted over the life of the note
to accretion of debt discount and issuance cost.
During the year ended December 31, 2020,
the Company repaid $158,065 in principal and $0 in interest.
The Second February 2020 Convertible
Loan Agreement
On February 11, 2020, the Company entered
into a loan agreement (the “Second February 2020 Loan Agreement”) with an individual (the “Second February 2020
Lender”), whereby the Second February 2020 Lender issued the Company a promissory note of $200,000 (the “Second February
2020 Note”). Pursuant to the Second February 2020 Loan Agreement, the Second February 2020 Note has interest of twelve percent
(12%). As additional consideration for entering in the Second February 2020 convertible Loan Agreement, the Company issued
a five-year warrant to purchase 6,666 shares of the Company’s common stock at a purchase price of $15.00 per share.
The Second February 2020 Note is convertible
into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at the lesser of (i)
a fixed conversion price equal to $13.50 per share or (ii) the price provided to investors in connection with (a) any private placement
offerings or one or more registered public offerings by the Company under the Securities Act, pursuant to which the Company receives
monies in the amount greater than $1,500,000 in exchange for securities of the Company, or (b) any private placement offerings
or one or more registered public offerings by the Company under the Securities Act in connection with its listing onto a national
securities exchange (a “Qualified Offering”).
The Second February 2020 Note matures on
the first (12th) month anniversary of its issuance date. In the event that the Offering’s Purchasers do not
choose to convert the Notes into the Common Stock on or prior to the Maturity Date and the Note is unpaid, the note will be convertible
at the lesser of the fixed conversion price or 75% multiplied by the lowest trade of the common stock during the twenty (20) consecutive
trading day period immediately preceding the date of the respective conversion.
The Conversion Price of the First February
2020 Note is subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities
convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise
Price. Such adjustment shall result in the Conversion Price being reduced to such lower purchase price, subject to carve-outs as
described therein.
The Company recorded a $33,340 debt discount
relating to original issue discount associated with this note. The debt discount is being accreted over the life of the note to
accretion of debt discount and issuance cost.
During the year ended December 31, 2020,
the Company converted $125,000 of principal and $0 of unpaid interest into the September 2020 Equity Raise.
The Company recorded a Loss on extinguishment
of debt of $136,115.
During the year ended December 31, 2020, the Company repaid
$175,000 in principal and $0 in interest.
The Third February 2020 Convertible
Loan Agreement
On February 25, 2020, the Company entered
into a loan agreement (the “Third February 2020 Loan Agreement”) with an individual (the “Third February 2020
Lender”), whereby the Third February 2020 Lender issued the Company a promissory note of $1,500,000 (the “Third February
2020 Note”). The Company received proceeds of $864,950 and converted notes payable of $385,000 in exchange for the note (see
Note 5). Pursuant to the Third February 2020 Loan Agreement, the Second February 2020 Note has interest of twelve percent
(12%).
The Third February 2020 Note is convertible
into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at the lesser of (i)
a fixed conversion price equal to $4.50 per share or (ii) the price provided to investors in connection with (a) any private placement
offerings or one or more registered public offerings by the Company under the Securities Act, pursuant to which the Company receives
monies in the amount greater than $1,500,000 in exchange for securities of the Company, or (b) any private placement offerings
or one or more registered public offerings by the Company under the Securities Act in connection with its listing onto a national
securities exchange (a “Qualified Offering”).
The Third February 2020 Note matures on
the first (12th) month anniversary of their issuance dates. In the event that the Offering’s Purchasers do
not choose to convert the Notes into the Common Stock on or prior to the Maturity Dates and the note is unpaid, the notes will
be convertible at the lower of the fixed conversion price or 75% multiplied by the lowest trade of the common stock during the
twenty (20) consecutive trading day period immediately preceding the date of the respective conversion.
The Conversion Price of the Third February
2020 Note are subject to adjustment for issuances of the Company’s common stock or any equity linked instruments or securities
convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion Price or Exercise
Price. Such adjustment shall result in the Conversion Price being reduced to such lower purchase price, subject to carve-outs as
described therein.
In accordance with ASC 470-50, since the
present value of the cash flows under the new debt instrument was at least ten percent different from the present value of the
remaining cash flows under the terms of the original debt instrument, the Company accounted for the note exchange as described
above as a debt extinguishment. The Company recorded a loss on debt extinguishment of $535,041. This represents the fair value
of the warrants issued $445,705 and a debt premium of $89,336. The note has an effective interest rate of 24%. The Company recorded
a debt discount of $160,714. This is made up of an original issue discount of $250,050 less a debt premium of $89,336.
During the year ended December 31, 2020,
the Company converted $1,500,000 of principal and $100,603 of unpaid interest into the September 2020 Equity Raise.
The April 2020 Convertible Note Offering
During April of 2020, the Company conducted
multiple closings of a private placement offering to accredited investors (the “April 2020 Convertible Note Offering”)
of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the
“April 2020 Investors”) for aggregate gross proceeds of $350,010. The April 2020 Convertible Note Offering accrues
interest at a rate of twelve percent per annum (12%). The April 2020 Convertible Note Offering mature on the six (6th)
month anniversary of their issuance dates.
The April 2020 Note is convertible into
shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at the lesser of (i) a
fixed conversion price equal to $13.50 per share after the maturity date or (ii) any private placement offerings or one or more
registered public offerings by the Company under the Securities Act in connection with its listing onto a national securities exchange
(a “Qualified Offering”).
The Company recorded a $50,010 debt discount
relating to original issue discount associated with these notes. The debt discount is being accreted over the life of the note
to accretion of debt discount and issuance cost.
During the year ended December 31, 2020,
the Company converted $350,010 of principal and $16,916 of unpaid interest into the September 2020 Equity Raise.
The June 2020 Convertible Loan Agreement
On June 19, 2020, the Company entered into
a loan agreement (the “June 2020Loan Agreement”) with an individual (the “June 2020 Lender”), whereby the
June 2020 Lender issued the Company a promissory note of $550,000 (the “June 2020 Note”). Pursuant to the June 2020
Loan Agreement, the June 2020 Note has interest of twelve percent (12%). As additional consideration for entering in the
June 2020 convertible Loan Agreement, the Company issued a five-year warrant to purchase 49,603 shares of the Company’s common
stock at a purchase price of $11.55 per share. The June 2020 Note matures on the first (12th) month anniversary of its
issuance date.
Upon default the June 2020 Note is convertible
into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) equal to the closing
bid price of the Company’s common stock on the trading day immediately preceding the date of the respective conversion.
The Company recorded a $67,500 debt discount
relating to original issue discount associated with this note. The Company recorded a $274,578 debt discount relating to 49,603
warrants and 5,424 shares issued to investors based on the relative fair value of each equity instrument on the dates of issuance.
The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2020,
the lender converted $59,200 of principal into the Second July 2020 Convertible Loan Agreement
During the year ended December 31, 2020,
the Company repaid $490,800 in principal and $16,944 in interest.
The First July 2020 Convertible Loan
Agreement
On July 01, 2020, the Company entered into
a loan agreement (the “First July 2020 Loan Agreement”) with an individual (the “First July 2020 Lender”),
whereby the First July 2020 Lender issued the Company a promissory note of $68,000 (the “First July 2020 Note”). Pursuant
to the First July 2020 Loan Agreement, the First July 2020 Note has interest of twelve percent (10%). The First July 2020
Note matures on June 29, 2021.
Upon default the First July 2020 Note is
convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) equal
to 61% multiplied by the lowest trade of the common stock during the twenty (15) consecutive trading day period immediately preceding
the date of the respective conversion.
During the year ended December 31, 2020
the Company repaid $68,000 in principal and $3,329 in interest.
The Second July 2020 Convertible
Loan Agreement
On July 17, 2020, the Company entered into
a loan agreement (the “Second July 2020 Loan Agreement”) with an individual (the “Second July 2020 Lender”),
whereby the Second July 2020 Lender issued the Company a promissory note of $250,000 (the “Second July 2020 Note”).
Pursuant to the Second July 2020 Loan Agreement, the Second July 2020 Note has interest of twelve percent (12%). The Second
July 2020 Note matures on July 17, 2021.
Upon default the Second July 2020 Note
is convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) equal
to the closing bid price of the Company’s common stock on the trading day immediately preceding the date of the respective
conversion.
The Company recorded a $46,750 debt discount
relating to original issue discount associated with this note. The Company recorded a $71,329 debt discount relating to 6,667 warrants
issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being
accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2020 the Company repaid $250,000
in principal and $0 in interest.
The July 2020 Convertible Note Offering
From July 2020 to September 2020, the Company
conducted multiple closings of a private placement offering to accredited investors (the “July 2020 Convertible Note Offering”)
of units of the Company’s securities by entering into subscription agreements with “accredited investors” (the
“July 2020 Investors”) for aggregate gross proceeds of $390,000. The July 2020 Convertible Note Offering accrues interest
at a rate of twelve percent per annum (12%). The July 2020 Convertible Note Offering mature on the six (6th) month anniversary
of their issuance dates.
The July 2020 Note Offering is convertible
into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at the lesser of (i)
a fixed conversion price equal to $12.75 per share after the maturity date or (ii) any private placement offerings or one or more
registered public offerings by the Company under the Securities Act in connection with its listing onto a national securities exchange
(a “Qualified Offering”).
Upon default the July 2020 Convertible
Note Offering is convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”)
equal to 61% multiplied by the lowest trade of the common stock during the twenty (15) consecutive trading day period immediately
preceding the date of the respective conversion.
The conversion feature of the July 2020
Convertible Note Offering provides for an effective conversion price that is below market value on the date of issuance. Such feature
is normally characterized as a beneficial conversion feature. When the Company records a BCF the relative fair value of the BCF
is recorded as a debt discount against the face amount of the respective debt instrument. The Company recorded a BCF and related
debt discount of $38,215, the discount is being accreted over the life of the Debenture to accretion of debt discount and issuance
cost.
The Company recorded a $158,078 debt discount
relating to 30,589 July 2020 Convertible Note Offering issued to investors based on the relative fair value of each equity instrument
on the dates of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance
cost.
During the year ended December 31, 2020,
the Company converted $390,000 of principal and $3,436 of unpaid interest into the September 2020 Equity Raise.
The August 2020 Convertible Loan
Agreement
On August 17, 2020, the Company entered
into a loan agreement (the “August 2020 Loan Agreement”) with an individual (the “August 2020 Lender”),
whereby the August 2020 Lender issued the Company a promissory note of $68,000 (the “August 2020 Note”). Pursuant to
the August 2020 Loan Agreement, the August 2020 Note has interest of twelve percent (12%). The August 2020 Note matures on
August 17, 2021.
Upon default the August 2020 Convertible
Note is convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”)
equal to 61% multiplied by the lowest trade of the common stock during the twenty (15) consecutive trading day period immediately
preceding the date of the respective conversion.
The Company recorded a $3,000 debt discount
relating to original issue discount associated with this note. The debt discount is being accreted over the life of the note to
accretion of debt discount and issuance cost.
During the year ended December 31, 2020
the Company repaid $68,000 in principal and $0 in interest.
The September 2020 Convertible Loan
Agreement
On September 23, 2020, the Company entered
into a loan agreement (the “September 2020 Loan Agreement”) with an individual (the “September 2020 Lender”),
whereby the September 2020 Lender issued the Company a promissory note of $385,000 (the “September 2020 Note”). Pursuant
to the September 2020 Loan Agreement, the September 2020 Note has interest of twelve percent (12%). The September 2020 Note
matures on September 23, 2021.
Upon default the Second July 2020 Note
is convertible into shares of the Company’s common stock, par value $.001 per share equal to the closing bid price of the
Company’s common stock on the trading day immediately preceding the date of the respective conversion.
The Company recorded a $68,255 debt discount
relating to original issue discount associated with this note. The Company recorded a $146,393 debt discount relating to 85,555
warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount
is being accreted over the life of the note to accretion of debt discount and issuance cost.
The October 2020 Convertible Loan
Agreement
On October 2, 2020, the Company entered
into a loan agreement (the “October 2020 Loan Agreement”) with an individual (the “October 2020 Lender”),
whereby the October 2020 Lender issued the Company a promissory note of $169,400 (the “October 2020 Note”). Pursuant
to the October 2020 Loan Agreement, the October 2020 Note has interest of twelve percent (6%). The October 2020 Note matures on
the first (12th) month anniversary of its issuance date.
Upon default the October 2020 Note is convertible
into shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”) equal to 75% of average
the lowest three trading prices of the Company’s common stock on the fifteen-trading day immediately preceding the date of
the respective conversion.
The Company recorded a $19,400 debt discount
relating to original issue discount associated with this note. The debt discount is being accreted over the life of the note to
accretion of debt discount and issuance cost.
The First December 2020 convertible
Loan Agreement
On December 9, 2020, the Company entered
into a loan agreement (the “First December 2020 Loan Agreement”) with an individual (the “First December 2020
Lender”), whereby the First December 2020 Lender issued the Company a promissory note of $600,000 (the “First December
2020 Note”). Pursuant to the First December 2020 Loan Agreement, the First December 2020 Note has interest of twelve percent
(12%). As additional consideration for entering in the First December 2020 convertible Loan Agreement, the Company issued
45,000 shares of the Company’s common stock. The First December 2020 Note matures on the first (12th) month anniversary
of its issuance date.
Upon default the First December 2020 Note
is convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) equal
to the closing bid price of the Company’s common stock on the trading day immediately preceding the date of the respective
conversion.
The Company recorded a $110,300 debt discount
relating to original issue discount associated with this note. The Company recorded a $113,481 debt discount relating to 45,000
shares issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount
is being accreted over the life of the note to accretion of debt discount and issuance cost.
The Second December 2020 Convertible
Loan Agreement
On December 30, 2020, the Company entered
into a loan agreement (the “Second December 2020 Loan Agreement”) with an individual (the “Second December 2020
Lender”), whereby the Second December 2020 Lender issued the Company a promissory note of $169,400 (the “Second December
2020 Note”). Pursuant to the Second December 2020 Loan Agreement, the Second December 2020 Note has interest of twelve percent
(6%). The Second December 2020 Note matures on the first (12th) month anniversary of its issuance date.
Upon default the Second December 2020 Note
is convertible into shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”) equal
to 75% of average the lowest three trading prices of the Company’s common stock on the fifteen-trading day immediately preceding
the date of the respective conversion.
The Company recorded a $18,900 debt discount relating to original
issue discount associated with this note. The debt discount is being accreted over the life of the note to accretion of debt discount
and issuance cost.
Note 9 – Related Party
Note receivable
October 2019 Cacher Loan Agreement
On October 28, 2019, the Company entered into a loan agreement
with Cacher Studios LLC (the “October 2019 Cacher Loan Agreement”) whereby Cacher Studios issued the Company a promissory
note in the principal amount of $11,450 (the “October 2019 Cacher Note”). The October 2019 Cacher Note has a maturity
date of October 28, 2020. Repayment is due from Cacher Studios LLC’s revenues, with 100% of net revenues due to the Company
until $2,500 in principal has been repaid, and 50% of net revenues due to the Company thereafter. Cacher Studios LLC is owned and
operated by Alexandra Frommer, daughter of Jeremy Frommer, the Company’s CEO. This investment is evaluated for impairment
if events or circumstances arise that indicate that the carrying amount of such assets may not be recoverable. The company recorded
an impairment of $11,450.
Convertible notes
Convertible notes payable – related
party as of December 31, 2020 and 2019 is as follows:
|
|
Outstanding Principal as of
|
|
|
|
|
|
|
|
|
Warrants granted
|
|
|
|
December 30,
2020
|
|
|
December 31,
2019
|
|
|
Interest
Rate
|
|
|
Maturity
Date
|
|
|
Quantity
|
|
|
Exercise
Price
|
|
The March 2018 Convertible Note Offering
|
|
$
|
-
|
|
|
$
|
400
|
|
|
|
14
|
%
|
|
|
April 2020
|
|
|
|
19,950
|
|
|
$
|
12.00
|
|
The February 2019 Convertible Note Offering
|
|
|
-
|
|
|
|
20,000
|
|
|
|
10
|
%
|
|
|
May 2020
|
|
|
|
440
|
|
|
|
18.00
|
|
The July 2020 Convertible Note Offering
|
|
|
-
|
|
|
|
-
|
|
|
|
10
|
%
|
|
|
January 2020
|
|
|
|
3,922
|
|
|
|
12.75
|
|
|
|
|
-
|
|
|
|
20,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Debt Discount
|
|
|
-
|
|
|
|
(13
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Debt Issuance Costs
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
|
20,387
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Current Debt
|
|
|
-
|
|
|
|
(20,387
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Long-Term Debt
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The March 2018 Convertible Note Offering
During the year ended December 31, 2018,
the Company conducted multiple closings of a private placement offering to accredited investors (the “March 2018 Convertible
Note Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited
investors” (the “Investors”) for aggregate gross proceeds of $239,400.
The March 2018 Convertible Note Offering
consisted of a maximum of $900,000, with an over-allotment option of an additional $300,000, of units of the Company’s securities
(each, a “March 2018 Unit” and collectively, the “March 2018 Units”), with each March 2018 Unit consisting
of (a) a 14% Convertible Secured Promissory Note (each a “March 2018 Note” and together the “March 2018 Notes”),
convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at a conversion
price of $12.00 per share (the “Conversion Price”), and (b) a four-year warrant (each a “Warrant and together
the “Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the Notes can
be converted into (“Warrant Shares”) at an exercise price of $12.00 per share (“Exercise Price”). The Notes
mature on the second (2nd) anniversary of their issuance dates.
The Conversion Price of the Note and the
Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any equity linked
instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion
Price or Exercise Price. Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase
price, subject to carve-outs as described therein.
The Company recorded a $84,854 debt discount
relating to 19,950 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance.
The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance cost.
During the year ended December 31, 2018,
the Company converted $239,000 of principal and $15,401 of unpaid interest into the August 2018 Equity Raise.
During the year ended December 31, 2020 the lender forgave $400
of principal and $70 of unpaid interest. This was recorded as a gain on settlement of debt on the Consolidated Statements of Comprehensive
Income (Loss).
The February 2019 Convertible Note
Offering
During the year ended December 31, 2019,
the Company conducted an offering to accredited investors (the “February 2019 Convertible Note Offering”) of units
of the Company’s securities by entering into subscription agreements with “accredited investors” (the “February
2019 Investors”) for aggregate gross proceeds of $20,000.
The February 2019 Convertible Note Offering
consisted of (a) a 10% Convertible Promissory Note (each a “February 2019 Note” and together, the “February 2019
Notes”), convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”)
at the lesser of (i) a fixed conversion price equal to $15.00 per share or (ii) the price provided to investors in connection with
(a) any private placement offerings or one or more registered public offerings by the Company under the Securities Act, pursuant
to which the Company receives monies in the amount greater than $1,500,000 in exchange for securities of the Company between February
21, 2019 and the date on which the Company’s consummates a listing onto a national securities exchange, or (b) any private
placement offerings or one or more registered public offerings by the Company under the Securities Act in connection with its listing
onto a national securities exchange (a “Qualified Offering”), and (b) a four-year stock purchase warrant (each a “Warrant
and together the “Warrants”) to purchase a quantity of shares of the Company’s common stock up to thirty-three
percent (33%) of the number of shares of common stock into which the underlying Notes may be converted, at an exercise price of
$18.00 per share (“Exercise Price”). During the year ended December 31, 2019 a total of 440 Warrants were issued in
conjunction with The February 2019 Convertible Note Offering.
The February 2019 Notes mature on the first
(1st) anniversary of their issuance dates. In the event that the Offering’s Purchasers do not choose to convert
the Notes into the Common Stock on or prior to the Maturity Dates, the principal and interest evidenced by the Note shall be mandatorily
converted upon the earlier of (i) the listing of the Common Stock onto a national securities exchange, or (ii) upon a Qualified
Offering.
The Company recorded a $2,465 debt discount
relating to 440 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance.
The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2019,
$20,000 of principal was converted from a promissory note into this offering.
During the year ended December 31, 2020,
the Company converted $20,000 of principal and $3,065 of unpaid interest into the September 2020 Equity Raise.
The July 2020 Convertible Note Offering
From July 2020 to September 2020, the Company conducted multiple
closings of a private placement offering to accredited investors (the “July 2020 Convertible Note Offering”) of units
of the Company’s securities by entering into subscription agreements with “accredited investors” (the “July
2020 Investors”) for aggregate gross proceeds of $50,000. The July 2020 Convertible Note Offering accrues interest at a rate
of twelve percent per annum (12%). The July 2020 Convertible Note Offering mature on the six (6th) month anniversary
of their issuance dates.
The July 2020 Note Offering is convertible
into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at the lesser of (i)
a fixed conversion price equal to $12.75 per share after the maturity date or (ii) any private placement offerings or one or more
registered public offerings by the Company under the Securities Act in connection with its listing onto a national securities exchange
(a “Qualified Offering”).
Upon default the July 2020 Convertible Note Offering is convertible
into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) equal to 61% multiplied
by the lowest trade of the common stock during the twenty (15) consecutive trading day period immediately preceding the date of
the respective conversion.
The conversion feature of the July 2020
Convertible Note Offering provides for an effective conversion price that is below market value on the date of issuance. Such feature
is normally characterized as a beneficial conversion feature. When the Company records a BCF the relative fair value of the BCF
is recorded as a debt discount against the face amount of the respective debt instrument. The Company recorded a BCF and related
debt discount of $9,812, the discount is being accreted over the life of the Debenture to accretion of debt discount and issuance
cost.
The Company recorded a $21,577 debt discount
relating to 3,922 July 2020 Convertible Note Offering issued to investors based on the relative fair value of each equity instrument
on the dates of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance
cost.
During the year ended December 31, 2020,
the Company converted $50,000 of principal and $630 of unpaid interest into the September 2020 Equity Raise.
Notes payable
Notes payable – related party as
of December 31, 2020 and 2019 is as follows:
|
|
Outstanding Principal as of
|
|
|
|
|
|
|
|
|
Warrants granted
|
|
|
|
December 31,
2020
|
|
|
December 31,
2019
|
|
|
Interest
Rate
|
|
|
Maturity
Date
|
|
|
Quantity
|
|
|
Exercise
Price
|
|
The June 2018 Frommer Loan Agreement
|
|
$
|
-
|
|
|
$
|
10,000
|
|
|
|
6
|
%
|
|
|
August 17, 2018
|
|
|
|
500
|
|
|
$
|
12.00
|
|
The July 2018 Schiller Loan Agreements
|
|
|
-
|
|
|
|
20,863
|
|
|
|
6
|
%
|
|
|
August 17, 2018
|
|
|
|
2,500
|
|
|
|
12.00
|
|
The June 2019 Loan Agreement
|
|
|
-
|
|
|
|
4,825,000
|
|
|
|
12.5
|
%
|
|
|
December 3, 2019
|
|
|
|
-
|
|
|
|
-
|
|
The December 2019 Gravitas Loan Agreement
|
|
|
-
|
|
|
|
300,000
|
|
|
|
6.7
|
%
|
|
|
March 1, 2020
|
|
|
|
-
|
|
|
|
-
|
|
The First January 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
6
|
%
|
|
|
January 2020
|
|
|
|
-
|
|
|
|
-
|
|
The Second January 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
5
|
%
|
|
|
January 2020
|
|
|
|
50
|
|
|
|
18.00
|
|
The Third January 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
10
|
%
|
|
|
January 2020
|
|
|
|
75
|
|
|
|
18.00
|
|
The Fourth January 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
7
|
%
|
|
|
February 2020
|
|
|
|
-
|
|
|
|
-
|
|
The January 2020 Rosen Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
February 2020
|
|
|
|
-
|
|
|
|
-
|
|
The February 2020 Banner Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
February 2020
|
|
|
|
49
|
|
|
|
18.00
|
|
The February 2020 Frommer Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
February 2020
|
|
|
|
15
|
|
|
|
18.00
|
|
The February 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
5
|
%
|
|
|
March 2020
|
|
|
|
75
|
|
|
|
18.00
|
|
The July 2020 Loan Agreement
|
|
|
-
|
|
|
|
-
|
|
|
|
5
|
%
|
|
|
August 2020
|
|
|
|
25
|
|
|
|
18.00
|
|
The September 2020 Goldberg Loan Agreement
|
|
|
16,705
|
|
|
|
-
|
|
|
|
7
|
%
|
|
|
September 2022
|
|
|
|
-
|
|
|
|
-
|
|
The September 2020 Rosen Loan Agreement
|
|
|
3,295
|
|
|
|
-
|
|
|
|
7
|
%
|
|
|
September 2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
20,000
|
|
|
|
5,155,863
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Debt Discount
|
|
|
(17,068
|
)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Debt Issuance Costs
|
|
|
-
|
|
|
|
(26,521
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,932
|
|
|
|
5,129,342
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Current Debt
|
|
|
(2,932
|
)
|
|
|
(5,129,342
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The June 2018 Frommer Loan Agreement
On June 29, 2018, the Company entered into a loan agreement
(the “June 2018 Frommer Loan Agreement”) with Jeremy Frommer, an officer and director of the Company, whereby the Company
issued Frommer a promissory note in the principal amount of $10,000 (the “June 2018 Frommer Note”). As additional consideration
for entering in the June 2018 Frommer Note Loan Agreement, the Company issued Frommer a four-year warrant to purchase 500 shares
of the Company’s common stock at a purchase price of $12.00 per share. Pursuant to the June 2018 Frommer Loan Agreement,
the June 2018 Frommer Note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 (the “June
2018 Frommer Maturity Date”). On November 8, 2018, the Company executed upon an agreement that extended the maturity date
of the June 2018 Frommer Agreement to March 7, 2019. As part of the extension agreement, the Company issued Frommer an additional
681 warrants to purchase common stock of the Company at an exercise price of $18.00. These warrants had a fair value of $4,645
which was recorded to loss on extinguishment of debt. On February 18, 2019 the Company executed upon an agreement that further
extended the maturity date of the June 2018 Frommer Agreement to March 30, 2019. As part of the extension agreement, the Company
issued Frommer an additional 692 warrants to purchase common stock of the Company at an exercise price of $18.00. On March 29,
2019, the Company entered into an agreement with Mr. Frommer that further extended the maturity date of this loan to May 15, 2019. On
June 29, 2019 the Company entered into an agreement with Mr. Frommer that further extended the maturity date of this loan to December
15, 2019. On December 15, 2019 the Company entered into an agreement with Mr. Frommer that further extended the maturity date to
May 15, 2020.
During the year ended December 31, 2020, the
Company converted $10,000 of principal and $2,748 of unpaid interest into the September 2020 Equity Raise and the June 2018 Frommer
Note is no longer outstanding.
The July 2018 Schiller Loan Agreement
On July 17, 2018, the Company entered into
a loan agreement (the “Second July 2018 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the
Company issued Schiller a promissory note in the principal aggregate amount of $25,000 (the “Second July 2018 Schiller Note”).
As additional consideration for entering in the Second July 2018 Schiller Loan Agreement, the Company issued Schiller a four-year
warrant to purchase 1,250 shares of the Company’s common stock at a purchase price of $12.00 per share. Pursuant to the Second
July 2018 Schiller Loan Agreement, the Second July 2018 Schiller Note bears interest at a rate of 6% per annum and payable on the
maturity date of August 17, 2018. Subsequent to the balance sheet date, on November 8, 2018 the Company executed upon an agreement
that extended the maturity date of this loan to March 7, 2019. As part of the extension agreement, the Company issued Schiller
warrants to purchase 1,698 shares of common stock of the Company at an exercise price of $18.00. On February 18, 2019 the Company
executed upon an agreement that further extended the maturity date of the Second July 2018 Schiller Loan Agreement to March 7,
2019. As part of the extension agreement, the Company issued Schiller an additional 1,726 warrants to purchase common stock of
the Company at an exercise price of $18.00. On March 29, 2019 the Company entered into an agreement with Mr. Schiller that further
extended the maturity date of this loan to May 15, 2019. On December 15, 2019 the Company entered into an agreement that further
extended the maturity date of this loan to May 15, 2020.
During the year ended December 31, 2019 $4,137
in principal was converted into the February 2019 Convertible Note Offering.
During the year ended December 31, 2020 the
Company repaid $20,863 in principal and $3,216 in interest.
The June 2019 Loan Agreement
On June 3, 2019, the Company entered into a
loan agreement (the “June 2019 Loan Agreement”), pursuant to which the Company was to be indebted in the amount of
$2,400,000, of which $1,200,000 was funded by September 30, 2019 and $1,200,000 was exchanged from the May 2016 Rosen Loan Agreement
dated May 26, 2016 in favor of Rosen for a joint and several interest in the Term Loan pursuant to the Debt Exchange Agreement.
The June 2019 Loan Agreement, the June 2019 Loan bears interest at a rate of 12.5% per annum, compounded annually and payable on
the maturity date of December 3, 2019 (the “June 2019 Maturity Date”) at which time all outstanding principal, accrued
and unpaid interest and other amounts due under the June 2019. In connection with the conversion of the May 2016 Rosen Loan Agreement
the Company recorded a debt discount of $92,752. The debt discount is being accreted over the life of the note to accretion of
debt discount and issuance cost.
On July 29, 2019, the Company entered into
the First Amendment Agreement to the June 2019 Loan Agreement pursuant to which the parties agreed to amend the June 2019 Loan
Agreement and the June 2019 Security Agreement so as to (i) increase the principal aggregate amount of the June 2019 Loan to $2,500,000,
and (ii) amend the provisions regarding the ranking of interest of such loan.
On August 12, 2019,
the Company entered into the Second Amendment Agreement to the June 2019 Loan Agreement pursuant to which the parties agreed to
further amend the June 2019 Loan Agreement and the June 2019 Security Agreement so as to (i) increase the principal aggregate amount
of the June 2019 Loan to $3,000,000, and (ii) amend the provisions regarding the ranking of interest of such loan.
On September 16, 2019,
the Company entered into the Third Amendment Agreement to the June 2019 Loan Agreement pursuant to which the parties agreed to
further amend the June 2019 Loan Agreement and the June 2019 Security Agreement so as to (i) increase the principal amount of the
June 2019 Loan to $4,000,000; and (ii) amend the provisions therein with regard to the ranking of security interests.
On October 10, 2019
the Company and investors entered into the Fourth Amendment Agreement to the June 2019 Loan Agreement, whereby the parties thereto
agreed to (i) increase the principal amount of the June 2019 Loan to $4,825,000; and (ii) amend the interest, conversion terms,
and other covenants of the note.
On February 27, 2020,
the Company entered into a fifth amendment agreement to the June 2019 Loan Agreement, whereby the parties agreed to amend Section
2.6 of the June 2019 Loan Agreement and provide for: (i) an additional 10% of shares to be issued at the time of conversion in
the event that the price per share (or unit, as applicable) of securities issued in a Qualified Public Offering (as such term is
defined in the Fifth Amendment) is below $15.00; and (ii) provide for the acceleration of all outstanding interest due on the Loan
upon the consummation of a Qualified Public Offering.
During year ended December 31, 2020, the Company
converted $4,325,000 of principal and $752,346 of unpaid interest into the September 2020 Equity Raise.
During the year ended December 31, 2020 the
Company repaid $500,000 in principal and $0 in interest.
The December 2019 Gravitas Loan Agreement
On December 23, 2019, the Company entered into
a loan agreement (the “December 2019 Gravitas Loan Agreement”), whereby the Company issued Gravitas a promissory note
in the principal amount of $300,000 (the “December 2019 Gravitas Note”). Pursuant to the December 2019 Gravitas Loan
Agreement, the December 2019 Gravitas Note has a flat interest payment of $20,000.
During the year ended December 31, 2020 the
Company repaid $300,000 in principal and $50,000 in accrued interest.
The
First January 2020 Loan Agreement
On
January 3, 2020, the Company entered into a loan agreement (the “First January 2020 Loan Agreement”) with an individual
(the “First January 2020 Lender”) whereby the First January 2020 Lender issued the Company a promissory note of $250,000
(the “First January 2020 Note”). Pursuant to the First January 2020 Loan Agreement, the First January 2020 Note has
an effective interest rate of 6%. As additional consideration for entering in the First January 2020 Loan Agreement, the Company
issued the First January 2020 Lender 1,333 shares of the Company’s common stock. The maturity date of the First January
2020 Note was January 15, 2020 (the “First January 2020 Maturity Date”) at which time all outstanding principal, accrued
and unpaid interest and other amounts due under the First January 2020 Note were due. The Company recorded a $16,000 debt
discount relating to the 1,333 shares issued to investors based on the relative fair value of each equity instrument on the dates
of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance cost.
During
the year ended December 31, 2020, the Company converted $250,000 in principal to the Third February 2020 Note (as defined in Note
8).
The
Second January 2020 Loan Agreement
On
January 14, 2020, the Company entered into a loan agreement (the “Second January 2020 Loan Agreement”) with an individual
(the “Second January 2020 Lender”), whereby the Second January 2020 Lender issued the Company a promissory note of
$10,000 (the “Second January 2020 Note”). Pursuant to the Second January 2020 Loan Agreement, the Second January 2020
Note has an effective interest rate of 5%. The maturity date of the Second January 2020 Note was January 24, 2020 (the “Second
January 2020 Maturity Date”), at which time all outstanding principal, accrued and unpaid interest and other amounts due
under the Second January 2020 Note were due. As additional consideration for entering in the Second January Loan Agreement, the
Company issued a five-year warrant to purchase 50 shares of the Company’s common stock at a purchase price of $18.00 per
share. The Company recorded a $580 debt discount relating to 50 warrants issued to investors based on the relative fair value
of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion
of debt discount and issuance cost.
During
the year ended December 31, 2020, the Company repaid $10,000 in principal and $500 in interest.
The
Third January 2020 Loan Agreement
On
January 22, 2020, the Company entered into a loan agreement (the “Third January 2020 Loan Agreement”) with an individual
(the “Third January 2020 Lender”), whereby the Third January 2020 Lender issued the Company a promissory note of $15,000
(the “Third January 2020 Note”). Pursuant to the Third January 2020 Loan Agreement, the Third January 2020 Note has
an effective interest rate of 10%. The maturity date of the Third January 2020 Note was January 29, 2020 (the “Third January
2020 Maturity Date”), at which time all outstanding principal, accrued and unpaid interest and other amounts due under the
Third January 2020 Note were due. As additional consideration for entering in the Third January Loan Agreement, the Company issued
a five-year warrant to purchase 75 shares of the Company’s common stock at a purchase price of $18.00 per share. The Company
recorded a $892 debt discount relating to 75 warrants issued to the Third January 2020 Lender based on the relative fair value
of each equity instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion
of debt discount and issuance cost.
During
the year ended December 31, 2020, the Company repaid $15,000 in principal and $1,500 in interest.
The
Fourth January 2020 Loan Agreement
On
January 23, 2020, the Company entered into a loan agreement (the “Fourth January 2020 Loan Agreement”) with an individual
(the “Fourth January 2020 Lender”) whereby the Fourth January 2020 Lender issued the Company a promissory note of
$135,000 (the “Fourth January 2020 Note”). Pursuant to the Fourth January 2020 Loan Agreement, the Fourth January
2020 Note has an effective interest rate of 7%. As additional consideration for entering in the First January 2020 Loan Agreement,
the Company issued the Fourth January 2020 Lender 750 shares of the Company’s common stock. The maturity date of the Fourth
January 2020 Note was February 23, 2020 (the “Fourth January 2020 Maturity Date”) at which time all outstanding principal,
accrued and unpaid interest and other amounts due under the Fourth January 2020 Note were due.
During the year ended December
31, 2020, the Company converted $135,000 in principal to the Second February 2020 Note (as defined below).
The January 2020 Rosen Loan Agreement
On January 14, 2020, the Company entered into
a loan agreement (the “January 2020 Rosen Loan Agreement”), whereby the Company issued a promissory note in the principal
amount of $150,000 (the “January 2020 Rosen Note”). Pursuant to the January 2020 Rosen Loan Agreement, the January
2020 Rosen Note accrues interest at a fixed amount of $2,500 for the duration of the note.
During the year ended December 31, 2020 the
Company repaid $150,000 in principal and $15,273 in interest.
The February Banner 2020 Loan Agreement
On February 15, 2020, the Company entered into
a loan agreement (the “February 2020 Banner Loan Agreement”), whereby the Company issued a promissory note in the principal
amount of $9,900 (the “February 2020 Note”) for expenses paid on behalf of the Company by an employee. Pursuant to
the February 2020 Loan Agreement, the February 2020 Note bears interest at a rate of $495. As additional consideration for entering
in the February 2020 Loan Agreement, the Company issued a five-year warrant to purchase 49 shares of the Company’s common
stock at a purchase price of $18.00 per share.
During the year ended December 31, 2020 the
Company repaid $9,900 in principal and $495 in interest.
The February 2020 Frommer Loan Agreement
On February 18, 2020, the Company entered into
a loan agreement (the “February 2020 Frommer Loan Agreement”) with Jeremy Frommer, an officer of the Company, whereby
the Company issued Frommer a promissory note in the principal amount of $2,989 (the “February 2020 Frommer Note”).
As additional consideration for entering in the June 2018 Frommer Note Loan Agreement, the Company issued Frommer a five-year warrant
to purchase 15 shares of the Company’s common stock at a purchase price of $18.00 per share. Pursuant to the February 2020
Frommer Loan Agreement, the note is payable on the maturity date of February 28, 2020 (the “February 2020 Frommer Maturity
Date”).
During the year ended December 31, 2020 the
Company repaid $2,989 in principal and $160 in interest.
The February 2020 Loan Agreement
On February 25, 2020, the Company entered into
a loan agreement (the “February 2020 Loan Agreement”) with an individual (the “February 2020 Lender”), whereby
the February 2020 Lender issued the Company a promissory note of $15,000 (the “February 2020 Note”). Pursuant to the February
2020 Loan Agreement, the February 2020 Note has an effective interest rate of 5%. The maturity date of the February 2020 Note was March
3, 2020 (the “February 2020 Maturity Date”), at which time all outstanding principal, accrued and unpaid interest and other
amounts due under the February 2020 Note were due. As additional consideration for entering in the February 2020 Loan Agreement, the Company
issued a five-year warrant to purchase 75 shares of the Company’s common stock at a purchase price of $18.00 per share. The Company
recorded a $801 debt discount relating to 75 warrants issued to investors based on the relative fair value of each equity instrument on
the dates of issuance. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2020, the Company
repaid $15,000 in principal and $750 in interest.
The July 2020 Loan Agreement
On July 30, 2020, the Company entered into
a loan agreement (the “July 2020 Loan Agreement”) with an individual (the “July 2020 Lender”), whereby
the July 2020 Lender issued the Company a promissory note of $5,000 (the “July 2020 Note”). Pursuant to the July 2020
Loan Agreement, the July 2020 Note has an effective interest rate of 5%. The maturity date of the July 2020 Note was August 06,
2020 (the “July 2020 Maturity Date”), at which time all outstanding principal, accrued and unpaid interest and other
amounts due under the July 2020 Note were due. As additional consideration for entering in the July 2020 Loan Agreement, the Company
issued a five-year warrant to purchase 25 shares of the Company’s common stock at a purchase price of $18.00 per share. The
Company recorded a $316 debt discount relating to 25 warrants issued to investors based on the relative fair value of each equity
instrument on the dates of issuance. The debt discount is being accreted over the life of the note to accretion of debt discount
and issuance cost.
During the year ended December
31, 2020, the Company repaid $5,000 in principal and $250 in interest.
The September 2020 Goldberg Loan Agreement
On September 15, 2020, the Company
entered into a loan agreement (the “September 2020 Goldberg Loan Agreement”) with Goldberg whereby the Company
issued a promissory note of $16,705 (the “September 2020 Goldberg Note”). Pursuant to the September 2020 Goldberg
Loan Agreement, the September 2020 Goldberg Note has an interest rate of 7%. The maturity date of the September 2020 Goldberg
Note is September 15, 2022 (the “September 2020 Goldberg Maturity Date”), at which time all outstanding
principal, accrued and unpaid interest and other amounts due under note are due. The September 2020 Goldberg Loan is secured
by the tangible and intangible property of the Company.
Since the September 2020 Goldberg Note has a make-whole provision if
the shares of the Company’s common stock issued to the lender in accordance with the Lender’s Exchange Agreement (see note
11) have a value equal to or less than $7,737,594 determined by using the lowest VWAP of the last 30 days prior to September 14, 2021.
The principal amount of the September 2020 Goldberg Note shall increase by 200% of the difference the initial consideration and the September
14, 2021 value. The Company has applied ASC 815, due to the potential for settlement in a variable quantity of shares. The make-whole
feature of gave rise to a derivative liability of $2,557,275, of which $2,540,570 was recorded as a loss on extinguishment of debt and
$16,705 as a debt discount. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2020 the
Company accrued interest of $347.
The September 2020 Rosen Loan Agreement
On September 15, 2020, the Company entered
into a loan agreement (the “September 2020 Rosen Loan Agreement”) with Rosen whereby the Company issued a promissory
note of $3,295 (the “September 2020 Rosen Note”). Pursuant to the September 2020 Rosen Loan Agreement, the September
2020 Rosen Note has an interest rate of 7%. The maturity date of the September 2020 Rosen Note is September 15, 2022 (the “September
2020 Rosen Maturity Date”), at which time all outstanding principal, accrued and unpaid interest and other amounts due under
the note are due. The September 2020 Rosen Loan is secured by the tangible and intangible property of the Company.
Since the September 2020 Rosen Note has a make-whole provision if the
shares of the Company’s common stock issued to the lender in accordance with the Lender’s Exchange Agreement (see note 11)
have a value equal to or less than $554,924 determined by using the lowest VWAP of the last 30 days prior to September 14, 2021. The principal
amount of the September 2020 Rosen Note shall increase by 200% of the difference the initial consideration and the September 14, 2021
value. The Company has applied ASC 815, due to the potential for settlement in a variable quantity of shares. The make-whole feature of
gave rise to a derivative liability of $504,413, of which $501,118 was recorded as a loss on extinguishment of debt and $3,295 as a debt
discount. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2020 the
Company accrued interest of $67.
Demand loan
On June 13, 2019,
Mark Standish, who was subsequently named Chairman of the Board, made non-interest bearing loans of $100,000 to the Company in
the form of cash. The loan is due on demand and unsecured. During the year ended December 31, 2019 the Company repaid $25,000 of
principal.
During the year ended
December 31, 2020 the Company repaid $75,000 of principal.
On December 17, 2019, Standish made non-interest
bearing loans of $150,000 to the Company in the form of cash. The loan is due on demand and unsecured.
During the year ended December 31, 2020 the
Company repaid $150,000 of principal.
On March 27, 2020, a lender made non-interest
bearing loans of $100,000 to the Company in the form of cash. The loan is due on demand and unsecured.
During the year ended December 31, 2020, the
Company converted $100,000 of principal and $6,707 of unpaid interest into the September 2020 Equity Raise.
On April 9, 2020, a lender made non-interest
bearing loans of $50,000 to the Company in the form of cash. The loan is due on demand and unsecured.
During the year ended December 31, 2020, the
Company converted $50,000 of principal into the September 2020 Equity Raise.
On April 21, 2020, a lender made non-interest
bearing loans of $100,000 to the Company in the form of cash. The loan is due on demand and unsecured.
During the year ended December 31, 2020, the
Company converted $100,000 of principal and $6,707 of unpaid interest into the September 2020 Equity Raise.
On July 6, 2020, a lender made non-interest
bearing loans of $100,000 to the Company in the form of cash. The loan is due on demand and unsecured.
During the year ended December 31, the Company
converted $100,000 of principal and $6,707 of unpaid interest into the September 2020 Equity Raise.
On August 10, 2020, a lender made non-interest
bearing loans of $40,000 to the Company in the form of cash. The loan is due on demand and unsecured.
During the year ended December 31, 2020 the
Company repaid $40,000 of principal.
On September 9, 2020, a lender made non-interest
bearing loans of $50,000 to the Company in the form of cash. The loan is due on demand and unsecured.
During the year ended December 31, 2020 the
Company repaid $50,000 of principal.
Officer compensation
During the year ended December 31, 2020 the Company paid $57,455
for living expenses for officers of the Company.
Note 10 – Derivative Liabilities
The Company has identified derivative instruments
arising from a make-whole feature in the Company’s notes payable at December 31, 2020. For the terms of the make-whole features
see the September 2020 Rosen Loan Agreement and the September 2020 Goldberg Loan Agreement in Note 9. The Company had no derivative
assets measured at fair value on a recurring basis as of December 31, 2020.
The Company utilized a Geometric Brownian Motion
(“GBM”) model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance
sheet date. The inputs utilized in the application of the GBM model included a starting stock price, an expected term of each debenture
remaining from the valuation date to maturity, an estimated volatility, and a risk-free rate.
Risk-free interest rate: The Company uses the
risk-free interest rate of a U.S. Treasury Note adjusted to be on a continuous return basis to align with the GBM model.
Dividend yield: The Company uses a 0% expected
dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.
Volatility: The Company calculates the expected volatility based on
the company’s historical stock prices with a look back period commensurate with the period to maturity.
Expected term: The Company’s remaining
term is based on the remaining contractual maturity of the convertible notes.
The following are the changes in the derivative liabilities
during the year ended December 31, 2020.
|
|
Year Ended
December 31, 2020
|
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Derivative liabilities as January 1, 2020
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
Addition
|
|
|
-
|
|
|
|
-
|
|
|
|
3,061,688
|
|
Conversion
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
Extinguishment Expense
|
|
|
|
|
|
|
|
|
|
|
-
|
|
Changes in fair value
|
|
|
-
|
|
|
|
-
|
|
|
|
(3,019,457
|
)
|
Derivative liabilities as December 31, 2020
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
42,231
|
|
Note 11 – Stockholders’ Deficit
Shares Authorized
Prior to July 13, 2020, the Company was authorized
to issue up to thirty-five million (35,000,000) shares of capital stock, of which fifteen million (15,000,000) shares are designated
as common stock, par value $0.001 per share, and twenty million (20,000,000) are designated as “blank check” preferred
stock, par value $0.001 per share. The designations, rights, and preferences of such preferred stock are to be determined by the
Company’s board of directors.
On July 13, 2020, the Company filed the Second
Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada, which authorize the issuance
of 100,000,000 shares of common stock, and 20,000,000 shares of preferred stock.
Preferred Stock
Series E Convertible Preferred Stock
On December 29, 2020 the Company entered into securities purchase agreements
with thirty-three accredited investors whereby the Investors have agreed to purchase from the Company an aggregate of 7,778 shares of
the Company’s Series E Convertible Preferred Stock, par value $0.001 per share and 2,831,715 warrants to purchase shares of the
Company’s common stock, par value $0.001 per share. The Series E Preferred Stock is convertible into a total of 1,887,810 shares
of Common Stock. The combined purchase price of one Conversion Share and one and a half warrant was $4.12. The aggregate purchase price
for the Series E Preferred Stock and warrants was $7,777,777.77. The Company has recorded $817,353 to stock issuance costs, which are
part of Additional Paid-in Capital.
The warrants are exercisable for a term of
five-years from the date of issuance, at an exercise price of $4.50 per share. The warrants provide for cashless exercise to the
extent that there is no registration statement available for the underlying shares of Common Stock.
The placement agent for the transaction and received cash compensation
equal to 10% of the aggregate purchase price and warrants to purchase 471,953 shares of the Company’s common stock, at an exercise
price of $5.15 per share (the “PA Warrants”). The PA Warrants are exercisable for a term of five-years from the date of issuance.
Reverse Stock Split
On July 25, 2019, following board of directors
approval, the Company filed a Certificate of Change to its Articles of Incorporation (the “Amendment”), with the Secretary
of State of the State of Nevada to effectuate a one-for-twenty (1:20) reverse stock split (the “Reverse Stock Split”)
of its common stock, par value $0.001 per share, without any change to its par value. The Amendment became effective on July 30,
2019. The number of common stock authorized was proportionately reduced pursuant to Reverse Stock Split. No fractional shares were
issued in connection with the Reverse Stock Split as all fractional shares were “rounded up” to the next whole share.
On August 17, 2020, following board of directors
approval, the Company filed a Certificate of Change to its Articles of Incorporation (the “Amendment”), with the Secretary
of State of the State of Nevada to effectuate a one-for-twenty (1:3) reverse stock split (the “Reverse Stock Split”)
of its common stock, par value $0.001 per share, without any change to its par value. The Amendment became effective on August
17, 2020. No fractional shares were issued in connection with the Reverse Stock Split as all fractional shares were “rounded
up” to the next whole share.
All share and per share amounts for the common
stock have been retroactively restated to give effect to the reverse split.
Common Stock
On January 4, 2019, the Company issued 100,000
shares of its restricted common stock to consultants in exchange for services at a fair value of $240,000.
On January 3, 2019, the Company issued 25,000
shares of its restricted common stock to consultants in exchange for services at a fair value of $70,050.
On January 30, 2020, the Company issued 50,000
shares of its restricted common stock to consultants in exchange for three months of services at a fair value of $585,000. These
shares were recorded as common stock issued for prepaid services and will be expensed over the life of the consulting contract
to share based payments. During the year ended December 31, 2020 the Company recorded $585,000 to share based payments.
On January 6, 2020, the Company issued 1,412
shares of its restricted common stock to settle outstanding vendor liabilities of $12,500. In connection with this transaction
the Company also recorded a loss on settlement of vendor liabilities of $4,233.
On March 5, 2020, the Company issued 2,153
shares of its restricted common stock to settle outstanding vendor liabilities of $25,000. In connection with this transaction,
the Company also recorded a gain on settlement of vendor liabilities of $1,098.
On March 13, 2020 the Company entered into an exchange agreement
with a warrant holder. The company agreed to exchange 5,833 warrants for 5,000 shares of the company common stock. In connection
with this agreement the company recorded a loss on conversion of warrants to stock of $5,772.
On March 19, 2020, the Company issued 20,000
shares of its restricted common stock to settle outstanding vendor liabilities of $72,048. In connection with this transaction
the Company also recorded a gain on settlement of vendor liabilities of $122,953.
On June 18, 2020, the Company issued 50,000
shares of its restricted common stock to consultants in exchange for services at a fair value of $525,000.
On June 29, 2020 the Company entered into an
exchange agreement with a warrant holder. The company agreed to exchange 5,833 warrants for 2,239 shares of the company common
stock and $10,000.
On July 3, 2020, the Company issued 15,000
shares of its restricted common stock to consultants in exchange for services at a fair value of $204,300.
On July 17, 2020 the Company issued 6,667 shares
of its restricted common stock to the Second February 2020 Lender in connection with the Second July 2020 convertible Loan Agreement.
On August 15, 2020, the Company issued 6,167
shares of its restricted common stock to consultants in exchange for services at a fair value of $50,693.
On August 21, 2020, the Company issued 20,000
shares of its restricted common stock to consultants in exchange for services at a fair value of $180,000.
On August 31, 2020, the Company issued 1,866
shares of its restricted common stock to consultants in exchange for services at a fair value of $15,842.
On September 11, 2020 the Second February 2020 Lender converted
$125,000 of the outstanding principal into 34,722 shares of the Company’s common stock.
On September 11, 2020 the February 2019 Convertible
Note Lender converted $70,542 of the outstanding principal and $112,888 of the outstanding interest into 64,124 shares of the Company’s
common stock.
On September 30, 2020, the Company issued 7,979
shares of its restricted common stock to consultants in exchange for services at a fair value of $21,304.
On December 14, 2020, the Company issued 10,417
shares of its restricted common stock to consultants in exchange for services at a fair value of $38,647.
On December 21, 2020, the Company issued 8,371
shares of its restricted common stock to employees in exchange for services at a fair value of $31,323.
During the year ended December 31, 2020 the
Company cancelled 50,650 shares of treasury stock.
Lender’s Exchange Agreement
On September 15, 2020, the Company exchanged $7,325,000 of principal
and $967,518 of accrued but unpaid interest of the Company’s debt obligations for $500,000 cash, 2,744,288 shares of Common
Stock, and 331,456 warrants (the “Lender’s Exchange Agreement”). The Company also issued the lenders notes totaling
$20,000. See note 9 for the September 2020 Goldberg Loan and the September 2020 Rosen Loan. The warrants have an exercise price
equal to $4.50 per share, expiring five years from the date of issuance. Since the terms of the original debt were exchanged this
was accounted for under extinguishment accounting. The Company determined this debt exchange was a debt extinguishment and the
Company recognized a loss on debt extinguishment of $4,915,327, including the derivative liability value.
September 2020 Equity Raise
Effective September 15, 2020, the Company consummated
an underwritten public offering (the “September 2020 Equity Raise”) of 1,725,000 units of securities (the “Units”),
with each Unit consisting of (i) one share of common stock, and (ii) one warrant to purchase one share of common stock (the “Warrants”).
The September 2020 Equity Raise was conducted pursuant to an Underwriting Agreement, dated September 10, 2020, by and between the
Company and The Benchmark Company, LLC, acting as the representative (the “Representative”) of the several underwriters
named therein (the “Underwriting Agreement”). In connection with the September 2020 Equity Raise, the Company granted
the underwriters a 45-day option to purchase up to 258,750 shares of common stock and/or 258,750 Warrants to purchase common stock
to cover over-allotments, if any.
The public offering price per Unit was $4.50.
The shares of common stock and Warrants were issued separately and were immediately separable upon issuance. Each Warrant represents
the right to purchase one share of common stock at an exercise price of $4.50 per share, expiring 5 years from the date of issuance.
The gross proceeds to the Company from the
September 2020 Equity Raise, before deducting underwriting discounts and commissions and other estimated offering expenses, and
excluding the exercise of any Warrants, was approximately $7,762,500.
In connection with the September 2020 Equity Raise, the Company converted
$3,183,667 of principal and accrued but unpaid interest of the Company’s debt obligations into 768,204 shares of Common Stock and
$570,416 warrants. See Notes 7, 8, and 9. The warrants have an exercise price equal to $4.50 per share, expiring five years from the date
of issuance. A down-round event was triggered in connection with the September 2020 Equity Raise, resulting in a contingent BCF that had
a value of $3,051,810. As these notes were fully converted in the September 2020 Equity Raise, the discount was expensed to accretion
of debt discount and issuance cost on the Consolidated Statements of Comprehensive Loss.
Stock Options
The Company applied fair value accounting for
all share-based payments awards. The fair value of each option granted is estimated on the date of grant using the Black-Scholes
option-pricing model.
The assumptions used for options granted during the year ended December
31, 2020 and 2019 are as follows:
|
|
December 30,
2020
|
|
|
December 30,
2019
|
|
Exercise price
|
|
$
|
8.55
|
|
|
$
|
13.2 - 6.60
|
|
Expected dividends
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected volatility
|
|
|
229.95
|
%
|
|
|
102.76
|
%
|
Risk free interest rate
|
|
|
0.25
|
%
|
|
|
1.61
|
%
|
Expected life of option
|
|
|
5.67 years
|
|
|
|
10 years
|
|
The following is a summary of the Company’s stock option activity:
|
|
Options
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Weighted
Average
Remaining
Contractual
Life
(in years)
|
|
Balance – December 31, 2018 – outstanding
|
|
|
294,158
|
|
|
$
|
25.2
|
|
|
|
3.27
|
|
Granted
|
|
|
9,667
|
|
|
|
9.66
|
|
|
|
10.01
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Cancelled/Modified
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Balance – December 31, 2019 – outstanding
|
|
|
303,825
|
|
|
|
24.48
|
|
|
|
2.51
|
|
Balance – December 31, 2019 – exercisable
|
|
|
303,825
|
|
|
|
24.48
|
|
|
|
2.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance – December 31, 2019 – outstanding
|
|
|
303,825
|
|
|
|
24.48
|
|
|
|
2.51
|
|
Granted
|
|
|
391,853
|
|
|
|
8.55
|
|
|
|
5.67
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Cancelled/Modified
|
|
|
(154,657
|
)
|
|
|
25.17
|
|
|
|
-
|
|
Balance – December 31, 2020 – outstanding
|
|
|
541,021
|
|
|
|
12.75
|
|
|
|
4.29
|
|
Balance – December 31, 2020 – exercisable
|
|
|
149,168
|
|
|
$
|
23.77
|
|
|
|
1.75
|
|
Option Outstanding
|
|
|
|
Option Exercisable
|
|
|
Exercise price
|
|
|
|
Number Outstanding
|
|
|
|
Weighted
Average
Remaining
Contractual
Life (in years)
|
|
|
|
Weighted
Average
Exercise
Price
|
|
|
|
Number Exercisable
|
|
|
|
Weighted
Average
Remaining Contractual
Life (in years)
|
|
$
|
12.75
|
|
|
|
541,021
|
|
|
|
4.29
|
|
|
|
23.77
|
|
|
|
149,168
|
|
|
|
1.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During the year ended December 31, 2018 the Company
granted options of 11,667 to consultants that has a fair value of $57,123. As of the date of this filing the company has not issued these
options and they are recoded as an accrued liability on the Consolidated Balance Sheet.
On May 7, 2020, the board of directors approved
the Jerrick Media Holdings, Inc. 2020 Omnibus Equity Incentive Plan (the “Plan”). Only employees, non-employee
directors and consultants are eligible for awards under the Plan. The Plan provides for awards in the form of options (incentive
stock options or nonstatutory stock options) restricted stock grants, and restricted stock unit grants. Up to 2,500,000 shares
of common stock may be issued under the Plan and the option exercise price of stock options granted under the Plan shall not be
less than 100% of the Fair Market Value (as defined in the Plan) (110% for 10% shareholders in the case of ISOs) of a share of
common stock on the date of the grant. The option exercise price may be payable in cash, surrender of stock, cashless exercise
or net exercise. Each grant awarded under the Plan shall be evidenced by a grant agreement and may or may not be subject to vesting.
The Plan is subject to the approval of the Company’s stockholders within one year of the date of adoption by the Board of
Directors. On July 8, 2020, the Company’s stockholders approved the Plan, which terminates on May 7, 2030. The Board of Directors
may amend or terminate the Plan at any time and for any reason. An amendment of the Plan shall be subject to the approval of the
Company’s stockholders only to the extent required by applicable laws, regulations or rules.
On May 13, 2020 the Company entered into an exchange agreement with
eight option holders. The company agreed to exchange 152,992 options previously issued under the 2015 Incentive Stock and Award Plan for
229,491 shares of the Company common stock. In connection with this agreement the Company recorded incremental compensation on the exchange
of options to stock of $$1,117,031.
On July 23, 2020 the Company granted options
to purchase 391,853 shares of the Company’s Common Stock to employees.
Stock-based compensation for stock options has been recorded
in the consolidated statements of operations and totaled $4,092,013 and $446,123, for the year ended December 31, 2020 and 2019,
respectively.
Warrants
The Company applied fair value accounting for
all share-based payments awards. The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes
option-pricing model.
The assumptions used for warrants granted during
the year ended December 31, 2020 are as follows:
|
|
December 31,
2020
|
|
|
December 31,
2019
|
|
Exercise price
|
|
$
|
4.50 - 18.00
|
|
|
$
|
18.00
|
|
Expected dividends
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected volatility
|
|
|
234.03% - 247
|
%
|
|
|
78.5%-116.92
|
%
|
Risk free interest rate
|
|
|
0.21% - 1.63
|
%
|
|
|
1.32% - 2.75
|
%
|
Expected life of warrant
|
|
|
5 years
|
|
|
|
4 – 5 years
|
|
Warrant Activities
The following is a summary of the Company’s
warrant activity:
|
|
Warrant
|
|
|
Weighted
Average
Exercise
Price
|
|
Balance – December 31, 2018 – outstanding
|
|
|
1,849,380
|
|
|
$
|
16.20
|
|
Granted
|
|
|
154,607
|
|
|
|
17.67
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
Cancelled/Modified
|
|
|
(1,756,584
|
)
|
|
|
15.96
|
|
Balance – December 31, 2019 – outstanding
|
|
|
247,403
|
|
|
|
15.75
|
|
Balance – December 31, 2019 – exercisable
|
|
|
247,403
|
|
|
|
15.75
|
|
|
|
|
|
|
|
|
|
|
Balance – December 31, 2019 – outstanding
|
|
|
247,403
|
|
|
|
15.75
|
|
Granted
|
|
|
5,921,071
|
|
|
|
4.70
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
Cancelled/Modified
|
|
|
(37,526
|
)
|
|
|
13.31
|
|
Balance – December 31, 2020 – outstanding
|
|
|
6,130,948
|
|
|
|
4.96
|
|
Balance – December 31, 2020 – exercisable
|
|
|
3,228,235
|
|
|
$
|
5.37
|
|
|
Warrants Outstanding
|
|
|
|
Warrants Exercisable
|
|
|
Exercise price
|
|
|
|
Number
Outstanding
|
|
|
|
Weighted
Average
Remaining
Contractual
Life
(in years)
|
|
|
|
Weighted
Average
Exercise Price
|
|
|
|
Number
Exercisable
|
|
|
|
Weighted
Average
Exercise Price
|
|
$
|
4.96
|
|
|
|
6,130,948
|
|
|
|
4.75
|
|
|
|
5.37
|
|
|
|
3,228,235
|
|
|
|
4.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On October 6, 2020, the underwriters for the
September 2020 Equity Raise partially exercised the over-allotment option and on October 8, 2020, purchased an additional 258,750
warrants, generating gross proceeds, before deducting underwriting discounts and commissions, of $2,588.
During the year ended December 31,
2020 a total of 214,080 warrants were issued with convertible notes (See Note 8 above). The warrants have a grant date fair
value of $1,520,449 using a Black-Scholes option-pricing model and the above assumptions.
During the year ended December 31, 2020, a total of 289 warrants
were issued with notes payable – related party (See Note 9 above). The warrants have a grant date fair value of $3,342 using
a Black-Scholes option-pricing model and the above assumptions.
During the year ended December 31, 2020, a total of 3,922 warrants were issued with convertible notes
payable – related party (See Note 9 above). The warrants have a grant date fair value of $37,927 using a Black-Scholes option-pricing
model and the above assumptions.
During the year ended December 31, 2020, some of the Company’s
warrants had a reset provision triggered that resulted in a lower exercise price. A deemed dividend of $18,421 was recorded to
the Statements of Comprehensive Loss.
During
the year ended December 31, 2019, a total of 44,397 warrants were issued with convertible notes (See Note 8 above). The warrants
have a grant date fair value of $252,533 using a Black-Scholes option-pricing model and the above assumptions.
During
the year ended December 31, 2019, a total of 42,968 warrants were issued with notes payable – related party (See Note 9
above). The warrants have a grant date fair value of $205,509 using a Black-Scholes option-pricing model and the above assumptions.
During
the year ended December 31, 2019, a total of 440 warrants were issued with convertible notes payable – related party (See
Note 9 above). The warrants have a grant date fair value of $2,465 using a Black-Scholes option-pricing model and the above assumptions.
During
the year ended December 31, 2019, a total of 43,322 warrants were issued with the August 2018 Equity Raise (See above). The warrants
have a grant date fair value of $334,985 using a Black-Scholes option-pricing model and the above assumptions.
During
the year ended December 31, 2019, a total of 14,148 warrants were issued in exchange for services. The warrants have a grant date
fair value of $122,777 using a Black-Scholes option-pricing model and the above assumptions.
Note 12 – Commitments and Contingencies
The CARES Act lifts
certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (“2017 Tax Act”). Corporate taxpayers
may carry back net operating losses (NOLs) originating between 2018 and 2020 for up to five years, which was not previously allowed
under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully
utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum
of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for 2019 and 2020. The CARES
Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead
of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act.
In addition, the CARES
Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally
eligible for 15-year cost-recovery and 100% bonus depreciation. The enactment of the CARES Act did not result in any material adjustments
to our income tax provision for the year ended December 31, 2020.
On March 26, 2020 and April 30, 2020, the Company received 2
separate loans pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the CARES Act.
When
the applications for PPP first opened up, there was limited available funding and much confusion surrounding the application process.
The Company initially submitted its application for the May 2020 PPP Loan in early April but received no response in the aftermath
of submitting the application. After consulting multiple advisors, the Company made the decision to apply elsewhere, due to the
rampant media coverage of institutions running out of funding and the Company’s need for the capital and belief that if
2 separate loans were approved, the remaining application could simply be withdrawn.
Therefore,
in late April, the company proceeded with applying for the April 2020 PPP Loan. After some conflicting communications regarding
acceptance, the Company attempted to contact the lender to clarify but got no response. After continued attempts to follow up
with both lenders, the Company received approval for the May 2020 PPP Loan and funding for the April 2020 PPP Loan on the same
day, followed the next day by the funding of the May 2020 PPP Loan. The Company immediately separated the funds for the April
2020 PPP Loan into a separate reserved bank account with the intention of returning the funds. However, after several attempts
to contact the lender with no response, the Company was faced with difficulty raising funds in the early-Covid economy and made
the decision to utilize the funds for operations and pursue an installment repayment plan when they were able to reach the lender.
As of the date of this filing, the Company has begun making repayments on the loan, absent a formal installment agreement due
to difficulties reaching the lender. The Company intends to complete repayment before the end of 2021.
As each company is only permitted
one loan under the CARES Act, there is a possibility the loan bay be called by the SBA and the Company would have to repay the
loan in full at such time.
Litigation
On or about June 25, 2020, Home Revolution, LLC
(“Home Revolution”) filed a lawsuit in the United States District Court for the District of New Jersey, Home Revolution,
LLC, et al. v. Jerrick Media Holdings, Inc. et al., Case No. 2:20-cv-07775-JMV-MF. The Complaint alleges,
among other things, that Creatd, Inc. breached the Membership Interest Purchase Agreement, as modified, and ancillary transaction documents
in connection with the acquisition of Seller’s Choice, LLC, from Home Revolution in September 2019. The Complaint additionally alleges
violation of the New Jersey Uniform Securities Law, violations of the Exchange Act and Rule 10b-5 thereunder, fraud, equitable accounting,
breach of fiduciary duty, conversion and unjust enrichment. After filing the Complaint but prior to our Answer date, Home Revolution
moved by order to show cause to have a receiver appointed by the Court to take over Creatd’s operations.
We submitted an opposition, and after oral arguments
on August 13, 2020, the Court denied the receiver request in its entirety. We then filed a Motion to Dismiss on August 14, 2020 on
a number of grounds, the most significant of which is that this is a simple (alleged) breach of Promissory Note case. Creatd is current on
all payments under the Note, and because both parties are New Jersey entities a mere breach of contract and/or collection-based case is
not appropriately venued in federal court. Upon receipt of our Motion to Dismiss, Home Revolution submitted an Amended Complaint,
presumably in an effort to cure the problems with the Complaint which we identified in the Motion to Dismiss. Home Revolution has
subsequently initiated a series of atypical procedures and, as a result, has (without following the Federal Rules of Civil Procedure)
moved for both default and to submit yet another newly Amended Complaint (the one precludes the other and vice versa).
After we submitted a motion to clear
up the above, the Court reinstated the matter to the docket and permitted Plaintiff to file the Second Amended Complaint (we
had no objection). We have filed a motion to dismiss the Second Amended Complaint. That will take some time to be
decided. We expect no major event to occur for the next 12 months. Finally, we believe the lawsuit lacks
merit and will vigorously challenge the action.
Lease Agreements
On May 5, 2018, the Company signed a 5-year
lease for approximately 2,300 square feet of office space at 2050 Center Avenue Suite 640, Fort Lee, New Jersey 07024. Commencement
date of the lease is June 1, 2018. The total amount due under this lease is $411,150.
On April 1, 2019, the Company signed a 4-year
lease for approximately 796 square feet of office space at 2050 Center Avenue Suite 660, Fort Lee, New Jersey 07024. Commencement
date of the lease is April 1, 2019. The total amount due under this lease is $108,229
The components of lease expense were as follows:
|
|
Year Ended
December 31,
2020
|
|
Operating lease cost
|
|
$
|
54,157
|
|
Short term lease cost
|
|
|
15,842
|
|
Total net lease cost
|
|
$
|
69,999
|
|
Supplemental cash flow and other information related
to leases was as follows:
|
|
Year Ended
December 31,
2020
|
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|
|
Operating lease payments
|
|
|
104,922
|
|
|
|
|
|
|
Weighted average remaining lease term (in years):
|
|
|
2.5
|
|
|
|
|
|
|
Weighted average discount rate:
|
|
|
13
|
%
|
Total future minimum payments required under
the lease as of December 31, 2020 are as follows:
Twelve Months Ending December 31,
|
|
|
|
2021
|
|
$
|
108,983
|
|
2022
|
|
|
114,627
|
|
2023
|
|
|
53,094
|
|
Total
|
|
$
|
276,704
|
|
Rent expense for the year ended December 31,
2020 and 2019 was $107,737 and $198,473, respectively.
Note 13 – Income Taxes
Components of deferred tax assets are as follows:
|
|
December 31,
2020
|
|
|
December 31,
2019
|
|
Net deferred tax assets – Non-current:
|
|
|
|
|
|
|
Depreciation
|
|
$
|
(145,749
|
)
|
|
$
|
(63,676
|
)
|
Amortization
|
|
|
21,096
|
|
|
|
7,437
|
|
Stock based compensation
|
|
|
1,653,617
|
|
|
|
659,384
|
|
Expected income tax benefit from NOL carry-forwards
|
|
|
8,780,233
|
|
|
|
5,229,445
|
|
Less valuation allowance
|
|
|
(10,309,197
|
)
|
|
|
(5,832,590
|
)
|
Deferred tax assets, net of valuation allowance
|
|
$
|
-
|
|
|
$
|
-
|
|
Income Tax Provision in the Consolidated Statements of Operations
A reconciliation of the federal statutory income tax rate and the
effective income tax rate as a percentage of income before income taxes is as follows:
|
|
For the
Year Ended
December 31,
2020
|
|
|
For the
Year Ended
December 31,
2019
|
|
|
|
|
|
|
|
|
Federal statutory income tax rate
|
|
|
21.0
|
%
|
|
|
21.0
|
%
|
State tax rate, net of federal benefit
|
|
|
6.5
|
%
|
|
|
6.5
|
%
|
|
|
|
|
|
|
|
|
|
Change in valuation allowance on net operating loss carry-forwards
|
|
|
(27.5
|
)%
|
|
|
(27.5
|
)%
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
The following is a reconciliation of the beginning
and ending amount of the unrecognized tax benefit for the years ended December 31, 2020 and 2019:
|
|
2019
|
|
|
2020
|
|
Balance at January 1,
|
|
$
|
-
|
|
|
$
|
68,000
|
|
Additions based on tax positions relating to the current year
|
|
|
68,000
|
|
|
|
-
|
|
Reductions for tax positions of prior years
|
|
|
-
|
|
|
|
(68,000
|
)
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
68,000
|
|
|
$
|
-
|
|
Based on the available objective evidence, management believes it
is more likely than not that the net deferred tax assets of the Company will not be fully realizable for the year ended December
31, 2020 and 2019. Accordingly, management had applied a full valuation allowance against net deferred tax assets as of December
31, 2020 and 2019.
As of December 31, 2020, the Company had approximately $37 million
of federal net operating loss carryforwards available to reduce future taxable income which will begin to expire in 2033 for both federal
and state purposes.
On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Act”)
was signed into law making significant changes to the Internal Revenue Code of 1986, as amended (the “Code”). The Act
reduces the federal corporate income tax rate from 35% to 21% effective for tax years beginning after December 31, 2017. ASC 470
requires the Company to remeasure the existing net deferred tax asset in the period of enactment. The Act also provides for immediate
expensing of 100% or the costs of qualified property that is incurred and placed in service during the period from September 27,
2017 to December 31, 2022. Beginning January 1, 2023, the immediate expensing provision is phased down by 20% per year until it
is completely phased out as of January 1, 2027. Additionally, effective January 1, 2018, the Act imposes possible limitations on
the deductibility of interest expense. As a result of the provisions of the Act, the Company’s deduction for interest expense
could be limited in future years. The effects of other provisions of the Act are not expected to have a material impact on the
Company’s financial statements.
On December 22, 2017, the SEC staff issued Staff Accounting Bulletin
No. 118 (“SAB 118”) to provide guidance on accounting for the tax effects of the Act. SAB 118 provides a measurement
period that begins in the reporting period that includes the Act’s enactment date and ends when an entity has obtained, prepared
and analyzed the information that was needed in order to complete the accounting requirements under ASC 720. However, in no circumstance
should the measurement period extend beyond one year from the enactment date. In accordance with SAB 118, a company must reflect
in its financial statements the income tax effects of those aspects of the Act for which the accounting under ASC 740 is complete.
SAB 118 provides that to the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete,
but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements.
The Company does not reflect a deferred tax asset in its financial
statements but includes that calculation and valuation in its footnotes. We are still analyzing the impact of certain provisions
of the Act and refining our calculations. The Company will disclose any change in the estimates as it refines the accounting for
the impact of the Act.
Federal and state tax laws impose limitations on the utilization of net
operating losses and credit carryforwards in the event of an ownership change for tax purposes, as defined in Section 382 of the Internal
Revenue Code. Accordingly, the Company’s ability to utilize these carryforwards may be limited as a result of an ownership change
which may have already happened or may happen in the future. Such an ownership change could result in a limitation in the use of the
net operating losses in future years and possibly a reduction of the net operating losses available.
Note 14 – Restatement of previously issued Interim Financial
Statements
On March 13, 2021, our audit committee concluded, after consultation
with management and the Company’s financial consulting firm, that our previously issued unaudited financial statements for the period
ended September 30, 2020, included in the Company’s Quarterly Reports of Form 10-Q for the period ended September 30, 2020, should
no longer be relied upon as a result of the change in accounting for a make-whole provision. We concluded that a derivative liability
of $3,041,688 should have been recorded as of September 30, 2020. The adjustments resulting therefrom, which are non-cash in nature,
but has no impact on previously reported cash, total assets, and revenues.
The following tables summarize the effects of
the restatements on the specific items presented in the Company’s historical unaudited interim consolidated financial statements
previously included in the Company’s Quarterly Reports on Form 10-Q as of and for the three months and nine months ended September
30, 2020:
Creatd, Inc.
Condensed Consolidated Balance Sheets
|
|
September 30, 2020
|
|
|
|
As previously
|
|
|
|
|
|
|
|
|
|
reported
|
|
|
Adjustment
|
|
|
As restated
|
|
Demand loan
|
|
$
|
50,000
|
|
|
$
|
(50,000
|
)
|
|
$
|
-
|
|
Note payable - related party, net of debt discount
|
|
|
3,295
|
|
|
|
(3,295
|
)
|
|
|
-
|
|
Note payable, net of debt discount and issuance costs
|
|
|
990,122
|
|
|
|
(16,705
|
)
|
|
|
973,417
|
|
Derivative liability
|
|
|
-
|
|
|
|
3,061,688
|
|
|
|
3,061,688
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Current Liabilities
|
|
|
2,742,147
|
|
|
|
2,991,688
|
|
|
|
5,733,835
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
3,320,534
|
|
|
|
2,991,688
|
|
|
|
6,312,222
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid in capital
|
|
|
67,812,570
|
|
|
|
(388,633
|
)
|
|
|
67,423,937
|
|
Accumulated deficit
|
|
|
(65,302,489
|
)
|
|
|
(2,603,055
|
)
|
|
|
(67,905,544
|
)
|
Total stockholders’ deficit
|
|
$
|
2,402,394
|
|
|
$
|
(2,991,688
|
)
|
|
$
|
(589,294
|
)
|
Creatd, Inc.
Condensed Consolidated Statements of Comprehensive Loss (Unaudited)
|
|
For the Three Months Ended
September 30, 2020
|
|
|
For the Nine Months Ended
September 30, 2020
|
|
|
|
As previously reported
|
|
|
Adjustment
|
|
|
As restated
|
|
|
As previously reported
|
|
|
Adjustment
|
|
|
As restated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accretion of debt discount and issuance cost
|
|
$
|
(6,370,557
|
)
|
|
$
|
2,312,271
|
|
|
$
|
(4,058,286
|
)
|
|
$
|
(6,697,778
|
)
|
|
$
|
2,312,271
|
|
|
$
|
(4,385,507
|
)
|
Loss on extinguishment of debt
|
|
|
(88,734
|
)
|
|
|
(4,915,326
|
)
|
|
|
(5,004,060
|
)
|
|
|
(623,774
|
)
|
|
|
(4,915,326
|
)
|
|
|
(5,539,100
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expenses, net
|
|
|
(6,551,779
|
)
|
|
|
(2,603,055
|
)
|
|
|
(9,154,834
|
)
|
|
|
(8,318,566
|
)
|
|
|
(2,603,055
|
)
|
|
|
(10,921,621
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income tax provision
|
|
|
(13,575,643
|
)
|
|
|
(2,603,055
|
)
|
|
|
(16,178,698
|
)
|
|
|
(20,703,631
|
)
|
|
|
(2,603,055
|
)
|
|
|
(23,306,686
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(13,575,643
|
)
|
|
$
|
(2,603,055
|
)
|
|
$
|
(16,178,698
|
)
|
|
$
|
(20,703,631
|
)
|
|
$
|
(2,603,055
|
)
|
|
$
|
(23,306,686
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common shareholders
|
|
|
(13,594,064
|
)
|
|
|
(2,603,055
|
)
|
|
|
(16,197,119
|
)
|
|
|
(20,722,052
|
)
|
|
|
(2,603,055
|
)
|
|
|
(23,325,107
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
$
|
(13,569,908
|
)
|
|
$
|
(2,603,055
|
)
|
|
$
|
(16,172,963
|
)
|
|
$
|
(20,726,426
|
)
|
|
$
|
(2,603,055
|
)
|
|
$
|
(23,329,481
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per-share data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per share
|
|
$
|
(3.20
|
)
|
|
$
|
(0.61
|
)
|
|
$
|
(3.81
|
)
|
|
$
|
(5.91
|
)
|
|
$
|
(0.74
|
)
|
|
$
|
(6.65
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
|
|
4,254,300
|
|
|
|
-
|
|
|
|
4,254,300
|
|
|
|
3,506,393
|
|
|
|
-
|
|
|
|
3,506,393
|
|
Creatd, Inc.
Condensed
Consolidated Statements of Cash Flows (Unaudited)
|
|
For the Nine Months Ended
|
|
|
|
September 30, 2020
|
|
|
|
As previously
reported
|
|
|
Adjustment
|
|
|
As restated
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(20,703,631
|
)
|
|
$
|
(2,603,055
|
)
|
|
$
|
(23,306,686
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accretion of debt discount and issuance cost
|
|
|
6,697,778
|
|
|
|
(2,312,271
|
)
|
|
|
4,385,507
|
|
Loss on extinguishment of debt
|
|
|
623,774
|
|
|
|
4,915,326
|
|
|
|
5,539,100
|
|
Net Cash Used In Operating Activities
|
|
$
|
(5,032,488
|
)
|
|
$
|
-
|
|
|
$
|
(5,032,488
|
)
|
Note 15 – Subsequent Events
Subsequent to December 30, 2020,
a lender converted $71,400 in outstanding debt into 35,469 shares of Common Stock.
Subsequent to December 31, 2020, the Company issued 1,473,000
stock options to employees of the Company. These stock options have an exercise price of $5.65 and vest partially 1 year from issuance
and partially 2 years from issuance.
Subsequent to December 31, 2020, a total of 333,130 warrants
were exercised, resulting in net proceeds to the Company of $1,272,672, the cancellation of 333,130 warrants, and the issuance
of 302,434 shares of Common Stock.
Subsequent to December 31, 2020 the Company issued a total of 120,000
shares to consultants.
Subsequent to December 31, 2020 the Company entered into a Membership
Interest Purchase Agreement under which the Company made an investment of $100,000 to the seller in exchange for 3.3% of membership
interest in the entity and invested $100,000 into a promissory note with an interest rate of 10% per annum.
Subsequent to December 31, 2020 a total
of 21 shareholders converted 6,198.78 shares of Series E Convertible Preferred Stock into 1,490,233 shares of the Company’s
Common Stock.
Subsequent to December 31, 2020 the Company repaid 2 promissory notes
and accrued interest totaling $992,420.